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Introduction 
 
The brain is an organ with a high energy demand. Over 90% of the energy produced by 
mitochondria in the brain is derived from oxygen and glucose carried by the circulation. Any 
decrease in oxygen causes a prompt fall in energy production and results in severe ischemic brain 
damage. 
Since surgery of the aortic arch requires manipulation and exclusion of the cerebral 
vascularization  the utilisation of optimal methods of cerebral function preservation is necessary to 
avoid ischemic brain injuries. 
Current brain protection strategies, involving reduction of cerebral oxygen consumption and/or 
maintenance of cerebral blood flow, include: 
• Deep Hypothermic Circulatory Arrest (DHCA) 
• Retrograde Cerebral Perfusion (RCP) 
• Antegrade Selective Cerebral Perfusion (ASCP) 
 
 
1.2    Historical notes 
The first attempt to replace the transverse aortic arch for aneurysm was made by Schafer and 
Hardin in 1952 (1). During the procedure the aorta and the arch vessels were temporary occluded 
keeping the lower body and the brain perfused by means of small bore polyethylene tubes. The 
patients did not survive the operation. Similar attempts (2) were subsequently made using different 
kind of shunts but mortality was still unacceptably high mainly due to cerebral complications. 
In 1955 Cooley introduced mild-surface-induced-hypothermia and temporary shunts extending 
from the ascending to the descending thoracic aorta with side arms to both the innominate and left 
common carotid arteries to replace the transverse aortic arch in two patients (3). The first patients 
died 6 days after surgery from cerebral ischemia due to thrombosis of the innominate limb of the 
shunt. The second patient died from respiratory complications. 
In 1957 DeBakey and Crawford first successfully replaced a transverse aortic arch using 
normothermic total Cardio Pulmonary Bypass (CPB) and cerebral perfusion involving  several 
pumps and cannulation of both subclavian and both carotid arteries (4). The utilisation of CPB with 
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temporary or permanent shunts for cerebral arterial perfusion was then adopted by many surgeons 
but mortality and adverse neurologic outcome continued to be excessively high. 
Shortly thereafter, based on a series of investigations on adult dogs documenting profound 
inhibition of cerebral metabolism with lowering of brain temperature and on successful utilisation 
of profound hypothermia during complex congenital heart lesions repair, Pierangeli (5) 
demonstrated that the use of DHCA for cerebral protection during aortic arch repair in adult patients 
was a far simpler and safer approach to the treatment of aortic arch pathology. The advantages of 
the hypothermic technique were immediately apparent and included a quiet, dry, motionless 
surgical field, which was unencumbered by temporary bypass grafts or perfusion cannulas. 
Excessive manipulation and dissection of the brachiocephalic vessels was no longer necessary. 
Since that time, the efficacy of DHCA has been widely accepted. However, the increasing 
utilisation of DHCA revealed some of its limitations especially when longer durations for complex 
aortic arch repairs were required. In the largest clinical experience reported to date, Crawford 
demonstrated that patients treated with periods of circulatory arrest longer of 40 and 65 minutes had 
an increased risk of stroke and early mortality, respectively (6). 
Thus, in an effort to extend the safe period of hypothermic circulatory arrest, adjunctive 
methods of brain protection have been recently explored. These include RCP and ASCP. 
RCP, was first described as a treatment for massive air embolism during CPB by Mills and 
Ochsner in 1980 (7). In 1982, Lemole (8) reported on the intermittent use of this technique during 
the repair of a dissected thoracic aorta. Intermittent and later continuous RCP was adopted by Ueda 
as a method of cerebral protection during procedures involving the aortic arch (9). Since then, RCP 
became very popular and good results have been reported. 
The recent new interest in ASCP was spearheaded by Frist in 1986 (10). He described a 
simplified technique of CPB and unilateral selective cerebral perfusion under conditions of 
moderate hypothermia for the treatment of selected patients with aortic arch aneurysms. However, 
ASCP did not become widely used until Kazui and colleagues indicated with a series of clinical and 
experimental investigations (11-13) important details of the perfusion technique including  
perfusion site, volume, pressure and temperature of the perfusate. 
 
 
 
Chapter 1  
 - 12 -
1.3   Deep hypothermic circulatory arrest 
 
The main hypothesis is that hypothermia depresses cerebral metabolism enough to allow a safe 
period of total circulatory arrest characterised by absence of detectable functional or organ 
derangements in early or late postoperative period. 
Hypothermia, oxygen consumption (Vo2) considered as a measure of cerebral oxygen 
metabolism (CMRO2) and Cerebral Blood Flow (CBF) are strongly coupling variables of 
paramount importance for brain protection. 
Cerebral metabolism in humans correlates exponentially with temperature (Fig.1). The relationship 
can be expressed according to van't Hoff's equation, where the 10logarithm of the metabolic rate is  
 
 
 
related linearly to temperature (14;15). Thus, cerebral metabolism is reduced approximately 5% to 
7% per each degree centigrade, which results in a prolonged tolerance for ischemia. 
CBF in humans is directly related to temperature, cerebral metabolism, and arterial carbon dioxide 
tension. CBF (together with CMRO2 ) decreases as brain temperature decreases. The influence of 
temperature on cerebral perfusion  is dependent on carbon dioxide management during CPB. Alpha-
stat management (temperature-uncorrected blood gases) maintains a better CBF to metabolism ratio 
during hypothermia than pH-stat management but has the potential disadvantage of cerebral 
hypoperfusion because of low arterial carbon dioxide tension (16). Alternatively, pH-stat 
management (temperature-corrected blood gases) with strongly uncoupled CBF and metabolism has 
the theoretical advantage of increasing cerebral perfusion and enhancing brain cooling, but possible 
drawbacks include raising intracranial pressure, increasing brain edema and brain embolism. 
DHCA is a well established method of brain preservation during cardiovascular operations. 
However, brain damage as a consequence of hypothermic circulatory arrest remains a frequent 
Figure 1. Temperature and oxygen consumption. 
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subtle complication. The optimal conditions for maximising cerebral protection during DHCA are 
not well established and DHCA utilisation varies among institutions. There is still controversy 
about basic aspects of implementing DHCA such as the best temperature at arrest, cooling and 
warming rate, pH strategy, hemodilution, and duration of circulatory arrest that may considered as 
safe. 
The available information do not allow the formulation of a table or a rigorously derived equation 
relating safe duration of total circulatory arrest to various temperatures based on rigorously derived 
rules. Knowledge of biologic systems in general indicates that the relationship should be expressed 
as the probability of no functional or structural damage (Fig 2). 
 
 
 
 
 
However, based on more recent clinical and laboratory investigations some indications can be 
achieved. In the largest clinical experience reported to date, Svensson reported in a series of 616 
patients (median DHCA time 31 minutes; range from 7 to 120) an overall stroke and early mortality 
rates of  7% and 10%, respectively. On univariate analysis, periods of circulatory arrest greater than 
40 and 65 minutes were indicated as predictors of stroke and early mortality, respectively (6). 
Reich and associates (17), consistent with our results (chapter 6), demonstrated that a deep 
hypothermic circulatory arrest time of 25 minutes or more is associated with memory and fine 
motor deficits and with prolonged hospital stay. Sakamoto and co-workers, in a laboratory 
investigation, indicated that a DHCA time shorter than 25 minutes was free of behavioral or 
histological evidence of brain injury (18). 
McCullough and colleagues recently demonstrated that the human cerebral metabolic rate is still 
17% of baseline at 15°C and that the safe duration of circulatory arrest at 15°C is only 29 minutes 
Figure 2. Duration of circulatory arrest and probability of “safe” circulatory arrest at   
different temperatures 
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(19). The same authors (20), in an animal model, demonstrated that metabolic activity is still 19% 
of baseline values at 18°C and 11% at 8°C. Thus, despite the dramatic reductions in cerebral 
metabolism and oxygen requirements with profound hypothermia, there is still an ongoing, 
continuous need of substrates to the brain. Circulatory arrest will lead to a continuous temperature-
dependent depletion of energy stores and an increase in intracellular acidosis that is due to anaerobic 
glycolysis and production of lactate. This cerebral ischemic insult is aggravated by hyperglycemia 
(21). The observation that significant residual metabolic activity is still present at 18°C is somewhat 
alarming and suggesting the idea that further metabolic suppression may be achieved by deeper 
levels of hypothermia. However, for brain temperatures between 18°C and 8°C a loss of 
autoregulation (20) has been demonstrated and the so-called “luxury perfusion” that results when 
cerebral blood exceeds metabolic demands is theoretically associated with an increased risk of brain 
embolism. These findings probably outline that circulatory arrest times of 45-60 minutes were too 
optimistically indicated as safe. 
 
1.4    Retrograde cerebral perfusion 
 
RCP is commonly used as an adjunct to DHCA during surgery of the thoracic aorta as a 
method to improve neurologic outcome. 
 
The CPB is usually instituted by means of bicaval cannulation and arterial cannulation with 
a shunt line between the arterial and venous lines that is clamped during antegrade cerebral blood 
flow. Central cooling is carried out within 20-30 minutes to produce profound hypothermia to core 
temperatures ranging from 10°-20°C. Depending on the institution criteria, as soon as 
electrencephalographic silence, jugular venous saturation or cooling for a specific time interval or 
temperature are obtained, the superior vena cava is snared, circulatory arrest is induced and the 
arterial line is clamped while the shunt line is opened  to allow the oxygenated blood to be diverted 
to the superior vena caval cannula (Fig.3).  Desaturated venous blood is returned to the heart/lung 
machine via cardiotomy suction placed in the open thoracic aorta and via the inferior vena cava 
cannula. After completion of the distal aortic anastomosis and reattachment of the arch vessels 
deairing of the open aortic arch is obtained by retrograde cerebral perfusion and backflushing via 
the femoral artery. Resumption of conventional CPB and rewarming are then accomplished.  Means 
of RCP flow monitoring generally include either a central venous catheter or a jugular bulb catheter. 
Near-infrared spectroscopy, transcranial  Doppler assessment of middle cerebral artery and central 
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retinal artery flow have been also used. Flow (100-500 mL/min) is usually adjusted to maintain 
central venous pressure in the range of 15 to 25 mm Hg. 
 
 
 
Hypothetical RCP neuroprotective mechanisms include maintaining of cerebral 
hypothermia, washout of embolic air or debris, cerebral perfusion and metabolic support. However, 
based on the conflicting results of clinical and animal laboratory studies, none of the proposed 
mechanisms of cerebral protection noted above are definitely established. 
 
Debate on the effectiveness of retrograde cerebral perfusion has in part centred on competent valves 
in the venous circulation as well as dominant collateral circulation via the azygos system 
circumventing brain tissue in human beings (22;23) (Fig 4). 
CARDIOPULMONARY BYPASS 
RETROGRADE CEREBRAL 
PERFUSION 
Figure 3. Retrograde cerebral perfusion. 
                Ox: Oxygenator 
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Figure 3.  Internal Jugular Vein; SV: Subclavian Vein; AV: Azygos 
vein; SVC: Superior Vena Cava; IVC: Inferior Vena Cava; RCP: 
Retrograde Cerebral Perfusion.
IJV: 
 
 
Furthermore, experimental studies investigating retrograde cerebral blood flow in animal models 
are of difficult interpretation because of interspecies differences in cerebral venous anatomy and 
widely varying experimental protocols. Canine models are limited by the presence of venous valves 
in the neck and head making necessary bilateral cannulation of the maxillary veins or perfusion of 
the superior sagittal sinus, not very relevant for the clinical application (24;25). More conventional 
cannulation is possible in the pig because there are no venous valves but there are some differences 
with humans in the proportion of flow going to the brain versus extracranial structures. 
However, from the experimental literature it seems possible to conclude that overall retrograde 
intracranial flow is in the range of 20% to 60% of values achieved with hypothermic 
cardiopulmonary bypass (26-28), but based on the capillary flow data, it is doubtful that RCP 
provides perfusion able to meet cerebral metabolic oxygen and substrates demand (29;30). 
 
From human and laboratory investigations of cerebral metabolism calculating cerebral 
oxygen consumption, pH and high-energy phosphates level modifications using magnetic resonance 
and/or spectrophotometry, RCP appears to provide inadequate metabolic support when compared to 
normothermic baseline conditions, CPB and ASCP but appears to be superior to DHCA alone 
(28;31-33). 
 
Figure 4. IJV: Internal Jugular Vein; SV: Subclavian Vein; AV: 
Azygos Vein; SVC: Superior Vena Cava; IVC: Inferior vena Cava; 
RCP: Retrograde Cerebral Pefusion 
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Reports on the effects of RCP on histopathology of the brain in animal models are numerous 
in literature and mostly comparative with DHCA and ASCP. 
Midulla demonstrates that although ASCP affords the best cerebral protection by all outcome 
measures, RCP provides clear improvement compared to HCA (33). 
Juvonen and associates reported that although effective washout of particulate emboli from the 
brain can be achieved with retrograde cerebral perfusion with inferior vena cava occlusion, no 
advantage of retrograde cerebral perfusion with inferior vena cava occlusion after embolization is 
seen from behavioural scores, electroencephalographic recovery, or histopathologic examination; 
retrograde cerebral perfusion with inferior vena cava occlusion results in greater fluid sequestration 
and mild histopathologic injury even in control animals (32). 
Results from Ye and associates suggested that antegrade cerebral perfusion prevented ischemic 
damage to the brain and retrograde cerebral perfusion provided some protection compared to 
DHCA alone but moderately severe damage occurred (34). 
Boeckxstaens and associates reported that nonhuman primates undergoing retrograde cerebral 
perfusion had greater glial edema than those having DHCA (35) and morphologic studies conducted 
by Mohri revealed development of focal infarctions in the brain, destruction of the blood-brain 
barrier and cerebral edema by retrograde cerebral perfusion (36). 
 
The relationship between use of RCP and clinical outcome is also unclear. Some authors 
reported RCP duration to be a predictor of death and adverse neurologic outcome (37;38), whereas 
others did not (39-41). 
Studies comparing clinical outcome obtained with RCP, DHCA and ASCP also yielded mixed 
results. Coselli (42) and Ehrlich (43) reported that the use of RCP resulted in less mortality and 
fewer neurologic dysfunctions than DHCA. Okita and associates in a prospective comparative study 
reported similar results in terms of hospital mortality and post operative new strokes in patients 
operated with RCP and ASCP. However, the prevalence of transient brain dysfunction was 
significantly higher in patients with RCP (44). In a recent study by Hagl and associates (45), in a 
group of patients requiring a period of “total cerebral protection” between 40 and 80 minutes, ASCP 
was associated with a reduced incidence of  transient neurologic dysfunction when compared to 
RCP and DHCA. 
 
In summary, based on human and laboratory investigations RCP neuroprotective mechanisms still 
remain controversial. When compared to ASCP, RCP seems to be less affective but still providing  
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some adjunctive brain preservation to DHCA probably due to continued cerebral cooling via veno-
arterial and veno-venous collateral circulation. 
 
1.5   Antegrade selective cerebral perfusion 
 
The earliest attempts to repair aortic arch operations relied on complex methods of 
extracorporeal cerebral perfusion. In 1957, DeBakey and associates reported a successful resection 
of an aortic arch aneurysm using normothermic cardiopulmonary bypass involving several pumps 
and cannulation of both subclavian and both carotid arteries (4). In 1958, these same authors 
reported a 75% overall mortality in a group of 24 patients undergoing ascending aorta and aortic 
arch repair (46). 
 
CPB perfusion technique was simplified by Dubost (47), Pierce (48) and their co-workers using 
a single pump with a Y connection of the arterial line. 
However, since that time, extracorporeal cerebral perfusion during aortic arch replacement was 
overshadowed by the growing interest and utilisation of circulatory arrest. 
 
More recently, the recognition that a) deep hypothermia provides a reduced safe time of 
circulatory arrest (40-65 minutes) (6) b) combining ASCP with moderate hypothermia much lower 
flow rates can be used and c) ASCP provides better cerebral protection than either DHCA or RCP 
(13;29;33;49) interest in ASCP was renewed. 
The new ASCP “era” was initiated in 1986 by Frist (10). He described a simplified CPB technique 
with partial brachiocephalic perfusion, low CPB flow (30 to 50 ml/Kg/min) and moderate systemic 
cooling (26° to 28°C). The arterial line from a single pump head had a Y shape to perfuse the 
femoral artery and either the innominate or left carotid arteries. Eight patients (out of 10) survived 
the operation and no postoperative stroke occurred. 
 
In 1991, Bachet and co-workers introduced a procedure employing  cold “cerebroplegia” 
and “open aortic anastomosis technique”. They perfused the innominate and left common carotid 
arteries with blood between 6° and 12°C through a separated pump and heat exchanger. In 54 
patients with arch aneurysms, mortality was 13% and only one episode of severe neurologic injury 
occurred (50). 
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Kazui introduced the use of separate arterial pump heads for the cerebral and systemic 
circulations in order to provide individual hypothermic perfusion at 25°C to each system. Cerebral 
perfusion was obtained by means of endo-luminal cannulation of the brachiocephalic and left 
common carotid arteries while the left subclavian artery was clamped or occluded with a Fogarty 
catheter to avoid the steal phenomenon (11) (Fig. 5). 
 
 
 
 
 
However, ASCP was not considered safe and its use varied among institution until Tanaka and co-
workers indicated in an elegant experimental study important perfusion details such as optimum 
perfusion flow rate, pressure and temperature. Based on somotosensory, cerebral metabolism and 
histopathologic findings, he suggested that the safe range of  flow rates for cerebral perfusion 
during moderate hypothermia (25°C) is greeter than 50% of the physiologic level with a perfusion 
pressure of no less than 30 mm Hg. In the clinical setting a perfusion volume of 10 ml/Kg/min is 
considered to be 50% or more of the  physiologic flow rate of cerebral circulation (12). 
 
Figure 5. Antergrade Selective Cerebral Perfusion 
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In summary, ASCP provides numerous advantages: 
• Hypothermic perfusion of the cerebral circulation both reduces basic metabolic requirements 
and provides continuous oxygen and nutrient supply to the brain. 
• The safe time of circulatory arrest is extended which can be relevant during complex aortic 
arch repairs. 
• The moderate levels of hypothermia, in contrast to deep hypothermia, permit a shorter total 
perfusion time and thus a lower likelihood of microembolism, coagulopathy, hemorrhage, 
pulmonary and renal dysfunction (51;52). 
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Aim of the thesis 
 
At the St. Antonius hospital, ASCP is currently being used as the first-choice method of 
cerebral protection during elective or urgent repairs of the thoracic aorta. 
Aim of the present thesis was to describe the surgical techniques and the cerebral monitoring 
used in patients undergoing operations on the aortic arch with the aid of ASCP and to find an 
answer to the following questions: 
 
1. Although ASCP represented an important advance in protecting the brain during operations 
on the thoracic aorta, neurological complications still occur frequently being cause of death 
or severely unpaired quality of life. Which preoperative and intraoperative variables have to 
be considered risk factors for hospital mortality and adverse neurologic outcome when 
ASCP is used?  
2. Does a relationship exist between the duration of ASCP and hospital mortality and adverse 
neurologic outcome? 
3. When ASCP is used, does a more extended aortic tissue replacement pose the patient at 
higher risk of hospital death or adverse neurologic outcome?  
4. Although ASCP has proved to be a reliable method of brain protection during surgery of the 
thoracic aorta, its use during aortic dissection surgery remains still controversial because 
manipulation and cannulation of the arch vessels are required. Is this fear reasonable? Is the 
risk increased by the utilisation of ASCP? 
5. When a short time of circulatory arrest is anticipated, has DHCA to be preferred to ASCP? 
6. Can the use of moderate hypothermia, as compared to profound hypothermia, result in a 
better postoperative renal and pulmonary function recovery?  
7. How long is the “safe” time of a deep hypothermic circulatory arrest if transient 
neurological dysfunction are considered? 
8. During aortic arch replacement different techniques are currently available for arch vessels 
reimplantation. Has the separated graft technique to be preferred to the others? Which are 
the advantages associated with this technique? 
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Abstract 
Optimal protection of the brain is of primary importance if surgery on the ascending aorta and arch 
is to succeed. Regardless of the technique used for brain protection, monitoring plays a key role. 
Based upon our experience since 1995 with antegrade selective cerebral perfusion (ASCP) and 
moderate hypothermia, we herein present our actual brain monitoring strategy during surgery on the 
ascending aorta and arch. 
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A major issue in surgery involving the aortic arch is how to obtain adequate protection of 
the brain. Three methods are currently used i.e. deep hypothermic circulatory arrest, deep 
hypothermic circulatory arrest in combination with retrograde cerebral perfusion, and antegrade 
cerebral perfusion. Since 1995, we have been using routinely antegrade selective cerebral perfusion 
(ASCP) with moderate hypothermia in every procedure where an arrest time of more than 30 
minutes is anticipated [1,2]. In the setting of moderate hypothermia (23°-25°C), monitoring of the 
brain is of primary importance as the brain metabolism is still considerable [3]. We describe the 
neuromonitoring system used during aortic arch surgery at our institution. 
 
Material and methods 
 
Bilateral radial artery pressure 
During antegrade selective cerebral perfusion, a radial artery pressure between 50 and 80 
mmHg is desirable [4]. This correlates usually with a cerebral flow of 10ml/kg/min. 
 
Electroencephalography (EEG) 
EEG monitoring was performed with an EEG expert system. A four-channel strip chart was 
registered for each patient: fronto-parietal and temporo-occipital leads on each hemisphere were 
used. In addition to strip chart registration, EEG signals were passed through a microcomputer for 
fast Fourier transform. In this format, the power of the EEG per unit of time has a strong 
relationship with brain function and, therefore, gives a good indication of the functional status of 
the brain. The expert system continuously calculated the asymmetry of both fronto-parietal and 
temporo-occipital leads. 
 
Bilateral Transcranial Doppler (TCD) 
A 2 MHz pulsed ultrasound device (EME-Nicolet, Madison, WI, USA) was used for 
transcranial measurements of the blood flow velocity of both middle cerebral arteries. Insonation of 
the middle cerebral artery was initiated at a depth of 50 mm. After individual adjustment of Doppler 
variables such as gain, sample volume, and power of ultrasound, the probe was fixed to a frame for 
the whole procedure (fig1). Both signals were observed continuously and were recorded during 
antegrade cerebral perfusion. 
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Figure 1. Bilateral transcranial Doppler and NIRS sensors on the patient’s head during surgery.  
 
Figure 2. The monitor shows a mean value for cerebral saturation for the right and left hemisphere. 
 
Near Infrared Spectroscopy (NIRS) 
Regional cerebral oxygen saturation (rSO2) was measured with the INVOS 4100 
(Somanetics, Inc., Troy, MI, USA). Cerebral oxymeter probes were placed on the left and right 
forehead, with the caudal border approximately 1 cm above the eyebrow and the medial edge at the 
midline (Fig 1). The INVOS 4100 uses two wavelengths of near-infrared light and measures the 
ratio of oxyhaemoglobin (HbO2) to the total haemoglobin (HbT), which is a percentage value of 
rSO2. The sensors contain a light-emitting diode (LED) and two detectors located at 30 and 40 mm 
from the LED, allowing removal of the extracranial distribution of scattered light by the application 
of a subtraction algorithm. The proximal detector receives less of a signal from deeper brain tissue, 
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whereas the distal detector measures the saturation of all the tissue, including skin, muscle tissue, 
skull and the ratio of the two can give a mean value for cerebral saturation (Fig. 2,3). 
 
 
Figure 3. Evolution of mean values of cerebral saturation in the course of surgery, as calculated by 
the NIRS system. 
Discussion 
 
 Antegrade selective cerebral perfusion at moderate hypothermia has been our method of 
choice for brain protection during surgery involving the aortic arch since 1995. Technical data on 
this technique have been described previously [4]. Our experience with this technique in more than 
400 patients has been reported recently [2]. At moderate hypothermia – usually nasopharyngeal 
temperatures between 23°C and 26°C – brain metabolism is still considerable, which makes it 
susceptible to ischemic damage in case of failure of the ASCP delivery system [3]. We recommend 
a four-fold monitoring system. From our experience, we have learned that every single system may 
fail during the intervention, and may lead to unnecessary actions (e.g. repositioning of the cannulas, 
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changes in cerebral blood flow or cerebral perfusion pressure…). The combination of various 
techniques provides the surgical team with a more reliable monitoring system. 
When we started using ASCP, we routinely used only bilateral radial artery pressure and EEG 
monitoring. The right radial artery pressure provides direct information of the perfusion pressure to 
the right cerebral hemisphere as one of the perfusion cannulas is routinely positioned in the 
brachiocephalic trunk; the left radial artery provides only indirect information of blood flow to the 
left hemisphere (the second perfusion cannula is positioned in the left common carotid artery) by 
collateral flow through the vertebral artery. However, in situations of an incomplete circle of Willis, 
the left radial artery pressure is not a reliable parameter. 
On several occasions, the EEG recordings have proven to be unreliable. The combination of a lower 
nasopharyngeal temperature and anaesthetic drugs (e.g. propofol…) may be sufficient to suppress 
all EEG activity; in addition, in situations of problems with the perfusion cannulas  (e.g. kinking of 
a cannula, malpositioning…) EEG activity is usually altered only after a few minutes, which may 
be enough to induce irreversible ischemic damage to the brain. 
Gradually, our monitoring system became more sophisticated. First, bilateral transcranial Doppler 
was added. It allows for a direct and bilateral monitoring of cerebral blood flow by measurement of 
the flow velocities in the middle cerebral artery. TCD ultrasound is the only available method to 
continuously assess changes in cerebral haemodynamics. Flow curves are routinely projected on a 
monitor, and can be checked by a member of the surgical team at any moment. Problems with the 
perfusion delivery system are immediately detected by alterations in the flow patterns to the middle 
cerebral artery. Especially in situations of acute aortic dissection, where proper positioning of the 
cannulas may be difficult and confounding, the TCD monitoring has proven to be an excellent tool. 
However, due to logistic problems – usually in emergency situations during the night – and 
differences in experience with the set-up of the TCD system, this system is not always available. 
Moreover, TCD monitoring has a failure rate of 10-15% depending on age, gender, and race of the 
patients. 
Finally, to overcome the logistic problem with the TCD monitoring, NIRS was compared with TCD 
monitoring in about 100 cases. It was found that these two systems were both “quick” detectors of 
problems with the cerebral perfusion system. However, the NIRS does not provide information on 
embolic phenomena, something that Doppler ultrasonography clearly indicates. Transcranial 
Doppler ultrasonography is necessary to document ASCP flow, whereas the oxymetry data indicate 
the effectiveness of a given flow in maintaining oxygenation. An advantage of the oxymeter is the 
clear numerical information provided, but a large variety in rSO2 exists between patients. As far as 
the NIRS is concerned, we feel that the measured saturation is not of primary importance, but we 
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consider the trends of the saturation observed during the intervention to be a better parameter for 
ischemic brain injury. This was also observed by Edmonds et al. [5].  
The complete set-up of all four monitoring systems usually takes 15 minutes. Even in “less 
experienced” hands, the procedure is usually smooth, but can take a few minutes more. We do not 
feel that a complex operation is made even more complex by the four-fold monitoring system. The 
combination of techniques offers the surgeon the comfort of adequate information on the cerebral 
blood flow; on the other hand, every single technique may fail and lead to unnecessary problems 
and stress. 
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Abstract 
   Objective. To determine independent predictors of neurologic outcome and hospital mortality 
after surgery of the thoracic aorta using moderate hypothermic circulatory arrest and antegrade 
selective cerebral perfusion. 
   Methods. Between November 1996 and June 2000, 96 consecutive patients (69 men, 27 women; 
mean age 63±10 years) underwent operations on the thoracic aorta with the aid of moderate 
hypothermic circulatory arrest and antegrade selective cerebral perfusion. Sixty-four patients were 
operated on electively (66.7%), 32 emergently (33.3%). Indications for surgery were: type A acute 
dissection in 30 patients (31.3%), chronic aneurysm in 66 (68.8%). Seventeen patients (17.7%) had 
undergone previous aortic/cardiac surgical procedures. The mean selective cerebral perfusion time 
was 52.2 ± 31.9 minutes (range, 18 to 220 minutes). Preoperative, intraoperative, and postoperative 
factors were analysed by univariate and multivariate analysis to identify predictors of hospital 
mortality and neurologic outcome. 
   Results. There were no operative deaths; the hospital mortality rate was 11.5% (11/96). Stepwise 
logistic regression revealed preoperative renal dysfunction (p = 0.021), type A acute dissection (p= 
0.053), coronary artery bypass grafting (p = 0.058), post-operative pulmonary complications (p = 
0.000) and repeat thoracotomy for bleeding (p = 0.027) as independent predictors of hospital 
mortality. One patient sustained a permanent neurologic deficit (1%).  
Coronary artery bypass grafting (P = 0.013), and postoperative cardiac complications (P = 0.049) 
were statistically associated with an increased risk of any (transient and permanent) neurologic 
dysfunction on univariate analysis. Stepwise logistic regression indicated coronary artery bypass 
grafting as independent factor for any neurologic dysfunction. 
   Conclusion. This study confirmed that selective cerebral perfusion is an effective method of 
cerebral protection allowing complex thoracic aorta operations to be  performed with  reduced risk 
of  hospital mortality and adverse neurologic outcome. We didn't find that the duration of selective 
cerebral perfusion time influence hospital mortality and any neurologic deficit. 
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The surgical treatment of aneurysms or dissections involving the thoracic aorta still remains 
one of the most complicated tactical challenges in cardiac surgery where cerebral protection is the 
primary concern. Various techniques including Deep Hypothermia with Circulatory Arrest 
(DHCA), Retrograde Cerebral Perfusion (RCP) through the superior vena cava, and antegrade 
Selective Cerebral Perfusion (SCP) have been introduced as  means to protect the central nervous 
system from ischemic damages during the period of arch exclusion. 
All three methods have both advantages and disadvantages. DHCA is technically less 
complicated and provides a still, bloodless operative field. However, there is a limited “safe” time 
of circulatory arrest and a prolonged Cardio-Pulmonary Bypass (CPB) time is required to cool 
down and re-warm the patient resulting in a number of pulmonary, renal, cardiac, endothelial 
dysfunctions as well as an increased microembolism production (1-5). Coagulative complications 
are associated with deeper levels of hypothermia. RCP (6,7), introduced to flash out potential 
embolic air or debris, prolongs the “safe” cerebral time and improves the cerebral cooling.  Arch 
vessels manipulation can be avoided with this technique.  However, all the complications associated 
with deep hypothermia and prolonged CPB time are not avoided and there may be a reduced 
surgical visibility because of the blood return to the arch vessels. SCP prolongs the “safe”  time of 
circulatory arrest, improves the cerebral cooling, may be used with moderate hypothermia and also 
provides a technical flexibility with an independent control of systemic and cerebral perfusion being 
possible (8,9). Arch vessels manipulation and cannulation as well as technical complexity and  
reduced surgical visibility are reported as drawbacks of this technique. 
In 1996, we begun using SCP with moderate hypothermia as a method of cerebral protection 
during surgery of the aortic arch. Our experience has been described before (10). Here we present 
an update on our continuing experience with 96 consecutive patients. The aim of the present study 
is to determine the independent predictors of hospital mortality and neurologic outcome in patients 
who underwent surgery of the aortic arch  with the aid of moderate hypothermic circulatory arrest 
and SCP. 
Materials and methods 
Patients’ profile.  From November 1996 to June 2000, 96 consecutive patients underwent surgical 
treatment of aortic disease involving the aortic arch. The records of all patients were examined 
retrospectively. There were 69 men (71.9%) and 27 women (28.1%)  having a mean age of 63 
years+/- 10.9 (+/- standard deviation) (range, 32 to 79 years). Thirty patients (31.3%) were operated 
on for type A acute dissection , 16 (16.7%) for chronic post-dissection aneurysm and 50 (52.1%) for 
degenerative aneurysm. Sixty-four patients (66.7%) were operated on electively, 32 (33.3%) 
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underwent emergent operations (30 patients sustained acute dissection and 2 impending aneurismal 
rupture). Associated  diseases included hypertension in 54 patients (56.3%), chronic obstructive 
pulmonary disease in 20 (20.8%), chronic renal dysfunction (defined as a creatinine serum level 
exceeding 2 mg/dl) in 7 (7.3%), coronary artery disease in 21 (21.9%) and diabetes in 5 (5.2%). 
Thirty-tree patients were smokers (34.4%). Ten patients (10.4%) had a history of previous central 
neurological deficit (8  transient ischemic attack and 2 stroke). Seventeen patients (17.7%) had 
undergone previous aortic/cardiac surgical procedures. Preoperative evaluation of cerebral 
circulation was performed with Doppler echocardiography, digital angiography, or both in all 
patients undergoing elective procedures. None of our patients had severe intra or extra-cranial 
carotid disease that required surgical correction. 
Operative technique. Median sternotomy was used in 91 patients (94.7%) and median sternotomy 
plus left antero-lateral thoracotomy in 5 (5.3%). Details of our cannulation technique and method of 
SCP with moderate circulatory arrest have been described previously (10). Briefly, after the patients 
were heparinized, cannulated and cooled on CPB to 22°-26°C of nasopharyngeal temperature using 
a centrifugal  pump (Biomedicus, Medtronic, Inc., Eden Praire, MN), systemic circulation was 
arrested and the aorta opened. With the patient in Trendelenburg position, 15 F retrograde coronary 
sinus cannulas  (Chase Medical Inc, Houston, TX), connected with the oxygenator with a separate 
single-roller pump head, were inserted into the innominate and left common carotid arteries through 
the aortic lumen. During cannulation, while keeping the arch vessels occluded, perfusion was 
continued in order to avoid air embolism. After the cannulas were properly placed, the balloon at 
the tip of the cannulas was manually inflated and held by an encircling tape to prevent displacement  
except in the case acute dissection involved the arch vessels. The left subclavian artery was clamped 
or occluded with a Fogarty catheter (IFM, Clearwater, FL)  in order to avoid the steal phenomenon. 
The cerebral perfusion was started at rate of 10 ml/min/kg and adjusted to maintain a right radial 
pressure between 40 and 70 mm of Hg. 
During open distal aortic anastomosis (8), blood perfusion to the lower half of the body from the 
femoral artery was arrested or reduced to  500 ml/min.   
Graft replacement was performed for aortic reconstruction in all cases. The extent of aortic 
replacement was as follows: ascending aorta and hemiarch replacement in 43 patients (44.8%), 
ascending aorta and total arch replacement in 31 patients (32.3%), total arch replacement in 16 
patients (16.7%), total arch and descending aorta replacement in 3 patients (3.1%). A complete 
thoracic aorta replacement (ascending aorta, aortic arch and descending aorta) was performed in 3 
patients (3.1%). The elephant trunk technique was performed in 7 patients (7.3%). En bloc (11) or 
separated graft techniques were used to re-implant the arch vessels in case of complete aortic arch 
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replacement. If acute dissection was present, the dissected aortic layers and two Teflon felt were 
sandwiched together with a monofilament suture. Concomitant procedures included aortic valve 
replacement in 32 patients (33.3%), modified Bentall procedure in 22 patients ( 22.9%), coronary 
artery bypass grafting in 12 patients (12.5%). 
 
Cardiopulmonary bypass data. The mean CPB time was 175.5 ± 52.1 minutes (range from 85 to 
430 minutes), and the mean aortic cross-clamp time was 108.8 ± 37.2 minutes (range from 37 to 
213 minutes). Complete circulatory arrest time, defined as the time between the systemic circulation 
suspension and the beginning of SCP, ranged from 1 to 11 minutes, mean 4 ± 1.9 minutes. The 
mean SCP time was 52.2 ± 31.9 minutes (range from 18 to 220 minutes): 41 patients (42.7%) had a 
SCP time longer than 45 minutes and, of them, 29 patients (30.2%) longer than 60 minutes. 
 
Statistical analysis. Statistical analysis was performed using SPSS 7.0 statistical software (SPSS 
Inc, Chicago, IL). Continuous variables were expressed as the mean ± one standard deviation, and 
categorical variables as percentages. All variables were first analyzed using univariate analysis 
(impaired two-tailed t test, Chi-square test or Fisher’s exact test when appropriated) to determine 
weather any single factor influenced hospital mortality and any (transient and permanent) 
neurologic dysfunction. A p values of less than 0.05 was taken to indicate statistical significance. 
Variables that achieved p less than 0.2 in the univariate analysis were examined using multivariate 
analysis by forward stepwise logistic regression to evaluate independent risk factors for hospital 
mortality and for any neurological outcome.  
 
Results 
 
In-Hospital Mortality. There were no operative deaths. Eleven patients died during 
hospitalization; the hospital mortality rate was 11.5%.  Of 11 patients, 5 were operated on for type 
A acute dissection, 2 for impending aneurysmal rupture, and 4 for true aneurysm. Additionally, 2 of 
those patients underwent a previous coronary artery bypass grafting operation. The hospital 
mortality for elective surgery was 4/64 (6.2%), and it was 7/32 (21.8%) for emergency surgery. 
Modes of death were Multi Organ Failure (n = 8), septic shock (n = 1), acute myocardial infarction 
(n = 1), bleeding (n= 1). 
On univariate analysis, the following factors had a significant influence on hospital mortality: 
emergent status (p = 0.038), post-operative renal failure (p = 0.001), post-operative pulmonary 
failure (p = 0.001) and repeat thoracotomy for bleeding (p = 0.005) (Table 1).  Multivariate analysis 
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revealed preoperative renal dysfunction (OR = 5.3; p = 0.021), type A acute dissection (OR = 3.7; p 
= 0.053), coronary artery bypass grafting (OR = 3.5; p = 0.058), post-operative pulmonary 
complications (OR = 11.3; p = 0.001), repeat thoracotomy for bleeding (OR = 4.8; p = 0.027) to be 
independent predictors of hospital-mortality (Table 2). The extent of aortic replacement and SCP 
duration were not correlated with hospital mortality. 
 
In-Hospital Morbidity.  A stroke occurred post-operatively in 1 of 96 patients (1.0%). That patient 
was a 62 years old man operated on, electively, for an atherosclerotic aneurysm involving the 
ascending aorta and the proximal portion of the aortic arch. Thus an ascending aorta and hemiarch 
replacement was performed. The SCP time was 29 minutes. He never regained consciousness after 
surgery, and a computed tomographic scan showed multiple cerebral infarctions. We suppose the 
stroke was due to an inadequate de-airing of the tubes. Patients who died during hospitalization 
didn’t suffer from cerebral complications. 
Transient neurologic dysfunction, defined as post-operative agitation, lethargy or confusion with 
negative tomographic scanning and complete resolution before discharge occurred in 8 patients 
(8.3%). Coronary artery bypass grafting (CABG) (p = 0.013), and postoperative cardiac 
complications (p = 0.049) were statistically associated with an increased risk of any neurologic 
dysfunction on univariate analysis (Table 1). Stepwise logistic regression indicated CABG (p = 
0.007) as independent predictor of any neurologic dysfunction (Table 3). 
Other post-operative complications were bleeding requiring a repeat thoracotomy in 8 patients 
(8.3%), pulmonary complications requiring a mechanical ventilatory support longer than 48 hours   
in 11 patients (11.5%), and renal failure requiring temporary haemodialysis in 11 patients (11.5%). 
Cardiac complications (17/96; 17.7%) included: acute myocardial infarction (n = 3), cardiac 
tamponade  (n =  2), congestive heart failure (n = 1), heart block requiring a pace-maker 
implantation  (n =  1),  left bundle-branch block   (n =  1),  atrial fibrillation (n = 11) . 
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Table 1. Univariate analysis of hospital mortality and adverse  neurologic 
outcome 
  Patients Hospital death
 
 
Any neurologic 
deficit 
 
 
Variables  No % No % p value No % p value
Gender Male 69 71.9 9 13 0.350 8 11.6 0.437 
 Female 27 28.1 2 7.4  1 3.7  
Age years 63±10.9 65±10 0.444 68.3±5.8 0.161 
Dissection Acute 30 31.3 6 20 0.115 3 10 0.354 
 Chronic 16 16.7 - -  - -  
 No 50 52.1 5 10  6 12  
Smoking Yes 33 34.4 4 12.1 1.000 2 6.1 0.714 
 No 63 65.6 7 11.1  7 11.1  
Hypert. Yes 54 56.3 6 11.1 1.000 6 11.1 0.727 
 No 42 43.8 5 11.9  3 7.1  
CAD Yes 21 21.9 2 9.5 1.000 4 19 0.087 
 No 75 78.1 9 12  5 6.7  
Diabetes Yes 5 5.2 - - 1.000 - - 1.000 
 No 91 94.8 11 12  9 9.9  
Chronic 
renal Yes 7 7.3 2 28.5 0.182 - - 1.000 
Failure No 89 92.7 9 10.1  9 10.1  
COPD Yes 20 20.8 3 15 0.693 3 15 0.389 
 
 No 76 79.2 8 10.5  6 7.9  
CVD Yes 10 10.4 2 20 0.321 - - 0.591 
 No 86 89.6 9 10.4  9 10.5  
Previous Aortic Yes 9 9.5 - - 0.592 - - 0.594 
operation No 87 90.5 11 12.6  9 10.3  
Previous 
AVR Yes 5 5.2 - - 1.000 - - 1.000 
 No 91 94.8 11 12  9 9.9  
Previous 
CABG Yes 5 5.2 1 20 0.463 1 20 0.395 
 No 91 94.8 10 10.9  8 8.8  
Emergency Yes 32 33.3 7 21.8 0.038 4 12.5 0.476 
 No 64 66.7 4 6.2  5 7.8  
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Table 1.Continued. 
    Hospital death   
Any neurologic 
deficit 
 
 
Variables  No % No % p value No % p value
Extent of  Asc 43 44.8 7 16.2 0.391 6 14 0.518 
Aortic 
replacement 
Asc+ 
Arch 31 32.3 3 9.6  1 3.2  
 Arch 16 16.7 1 6.2  2 12.5  
 Asc+ 
Arch + 
Desc 
3 3.1 - -  - -  
 Arch+ 
Desc 3 3.1 - -  - -  
CABG Yes 12 12.5 3 25 0.138 4 33.3 0.013 
 No 84 87.5 8 9.5  5 6  
Bentall Yes 22 22.9 3 13.6 0.710 - - 0.113 
 No 74 77.1 8 10.8  9 12.2  
AVR Yes 32 33.3 5 15.6 0.498 4 12.5 0.476 
 No 64 66.7 6 9.3  5 7.8  
CPB time minutes 175.5±52.1 219.5±94 0.110 189.8±46.8 0.288 
Ao CC time minutes 108.8±37.2 113.1±38 0.617 109±52.1 0.860 
SCP time minutes 52.2±31.9 58.8±34.4 0.257 60.6±42.8 0.725 
CCA time minutes 4±1.9 3.3±1.5 0.184 4.5±2.9 0.802 
Transient  Yes 8 8.3 2 25 0.228 - - - 
neurologic 
dysfunction 
No 88 91.7 9 10.2  - -  
Permanent  Yes 1 1 - - 1.000 - -  
neurologic  
dysfunction 
No 95 99 11 11.5  - -  
Postop. Renal  Yes 11 11.5 7 63.6 0.001 1 9.1 1.000 
Failure No 85 88.5 4 4.7  8 9.4  
Postop. 
Pulmonary  
Yes 11 11.5 7 63.6 0.001 2 18.2 0.264 
dysfunction No 85 88.5 4 4.7  7 8.2  
Postop. Cardiac  Yes 17 17.7 2 11.7 1.000 4 23.5 0.049 
complications No 79 82.3 9 11.3  5 6.3  
Rethoracotomy 
for  
Yes 8 8.3 4 50.0 0.005 1 12.5 0.559 
bleeding No 88 91.7 7 7.9  8 9.1  
CAD=coronary artery disease; COPD=chronic obstructive pulmonary disease; CVD=cerebral 
vascular disease; AVR=aortic valve replacement; CABG=coronary artery bypass grafting; 
Asc=ascending aorta; Arch=aortic arch; Desc=descending aorta; CPB=cardiopulmonary bypass;  
Ao CC=aortic cross clamp; SCP=selective cerebral perfusion; CCA=complete circulatory arrest 
 
                                                                                                                                           Risk analysis 
 - 45 -
 
 
Comment 
 
Brain and spinal cord protection from ischemic and embolic injury, avoidance of 
coagulopathy and haemorrhage, and prevention of myocardial damage during extracorporeal 
circulation are primary concerns during surgery of the thoracic aorta. Since the establishment  of 
cardioplegia as a method of protecting the myocardium, a successful operative outcome bases itself 
on the appropriate selection of cerebral protection techniques.  
Deep hypothermia with circulatory arrest, first used  by Pierangeli and co-workers (1-2) in 
1974 in a prosthetic replacement of the aortic arch, is the most widely used method. However,   
“safe” time of circulatory arrest constraints (3,4,12), lengthy perfusion times and deeper levels of 
hypothermia,  have prompted a renewed interest in other cerebral protective techniques.  
Retrograde cerebral perfusion, first reported in 1980 as a treatment for massive air embolism 
during CPB (13), was later introduced in association with deep hypothermic circulatory arrest as a  
Table 2. Multivariate analysis for significant Determinants of Hospital Mortality 
Predictor Coefficient ±  SE OR 95%   CL p-value 
Type A acute dissection 2.106 ± 1.08 3.7 0.973 – 69.414 0.053 
Preoperative renal 
 Dysfunction 
4.317 ± 1.86 
5.3     1.919 –2228.6629 0.021 
CABG 3.004 ± 1.58 3.5  0.900 – 451.607 0.058 
Post-operative pulmonary 
complication 
5.726 ± 1.69 
11.3 11.020 – 8541.400 0.001 
Rethoracothomy 3.378 ± 1.53 4.8 1.452 – 591.661 0.027 
CABG = Coronary Artery By-pass Grafting 
Table 3. Multivariate analysis for significant Determinants of  Transient 
Neurologic Deficit 
Predictor Coefficient ±  SE OR 95%  CL p-value 
CABG 2.066 ± 0.76 7.2 1.758-35.493 0.007 
CABG = Coronary Artery By-pass Grafting 
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method of cerebral protection during surgery of the aortic arch and good results have been reported 
(6,14). Advantages of RCP include uniform brain cooling, the capacity of limiting cerebral 
embolism and flushing of toxic metabolites that accumulate during HCA. Reports of successful 
outcomes after the use of RCP for periods longer then 60 minutes are not uncommon (14). 
However, all the complications associated with both deep hypothermia and prolonged CPB time are 
not avoided with this technique; retrograde cerebral perfusion capabilities and  protective 
mechanism remain still controversial (15-18). We had a very limited experience with RCP with 
results similar to those obtained with DHCA (19). 
In November 1996 we begun using SCP with moderate hypothermic circulatory arrest as 
described by Kazui and co-workers (11,12) during surgery of the aortic arch. This method is 
basically free from time limitation with regard to brain protection allowing unhurried and 
meticulous  surgical reconstruction of the aortic arch. In our series the mean SCP time was 52.2 ± 
31.9 minutes and 30.2% of the patients required SCP time longer than 60 minutes for an adequate 
surgical repair to be performed.  In the present study 1 patient out of 96 (1%) sustained a permanent 
neurologic complication. This compares favourably with other reports using the same technique of 
SCP (0 to about 5.4%) (20-24), DHCA (0 to about 11%) (3,4,19), and RCP (0 to about 12.5%) 
(6,7,14,25).  
The overall in-hospital mortality rate was 11.5%. This compares favourably with other 
reports. Kazui and co-workers (24) reported an overall hospital mortality rate of 12.7% in 220 
patients undergoing a total arch replacement procedure. Chronic renal failure, long  pump time, and  
shock were independent determinants of in-hospital mortality on multivariate analysis. SCP time 
did not significantly  influenced hospital mortality or neurologic outcome.  
Dossche and co-authors (22) reported a hospital mortality of 8.6%. In their series SCP had a 
favourable impact on hospital mortality and neurologic outcome. Bachet and associates (23) 
reported a hospital mortality of 16.9%; extension of aortic replacement and age greater than 60 
years were prominent risk factors while duration of circulatory arrest, CPB and SCP had no 
significant influence on the hospital outcome. Ueda (14) reported a  hospital mortality of 10% in a 
group of patients where RCP was used as a method of brain protection; RCP time, pump time and 
age were indicated as risk factors for hospital mortality on multivariate analysis. We found in our 
series that preoperative renal dysfunction, type A acute dissection, coronary artery bypass grafting, 
postoperative pulmonary failure, repeat thoracotomy for bleeding were independent predictors of 
hospital-mortality (Table 2). 
The extent of aortic replacement and SCP duration were not correlated with hospital 
mortality. Both technical complexity and manipulation of the arch vessels in case of acute 
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dissection or in the presence of loose atheroma in the aortic arch are indicated as principle 
drawbacks of SCP with moderate circulatory arrest. With our growing experience we found very 
simple to insert the cannulas into the arch vessels; in this series it took a mean time of complete 
circulatory arrest of 4.1 minutes. We use 15 F retrograde coronary sinus cannulas; they are made of 
silicon, flexible and can be placed toward the patient’s head not obscuring the operative field. In the 
case of acute dissection it was always easy to insert the cannula through the aortotomy into the true 
lumen and in case of a clear involvement of the arch vessels by the acute dissection a 3-branched 
graft was used. Up to date no complications resulting from cannulation of supraaortic vessels were 
observed in our experience, or in those of Kazui (24), Dossche (22), Bachet (23).  
In conclusion, this study confirmed that selective cerebral perfusion is an effective method 
of cerebral protection allowing complex thoracic aorta operations to be  performed with  low risk of  
hospital mortality and adverse neurologic outcome. We didn’t find that the duration of selective 
cerebral perfusion time influenced hospital mortality and any neurologic deficit. 
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Abstract 
 
Objective. We retrospectively analysed hospital mortality and neurologic outcome after surgery on 
the thoracic aorta with the aid of  antegrade selective cerebral perfusion to determine a  predictive 
risk model. 
Methods. Between October 1995 and May 2001, 413 patients (mean age 63.0±11.5 years) 
underwent surgery on the thoracic aorta using antegrade selective cerebral perfusion. Indication for 
surgery was acute type A dissection in 116 patients (28.1%), degenerative aneurysm in 227 
(55.0%), post-dissection aneurysm in 70 (16.9%). One hundred-twenty-five patients (30.3%) were 
operated on urgently; concomitant procedures were performed in 171 patients (41.4%). Mean 
cerebral perfusion time was 63.0±38.7 minutes (range, 16-220 minutes). Preoperative and 
intraoperative factors were evaluated by univariate and multivariate analysis to identify predictors 
of hospital mortality and neurological outcome 
Results. The hospital mortality rate was 9.4%. Stepwise logistic regression revealed urgency status 
(p=0.000; OR=19.9) and recent history of recent central neurologic event (p=0.004; OR=8.0) to be 
independent determinants for hospital mortality. Temporary neurological dysfunction occurred in  
20 patients (5.1%). Urgency status (p=0.005; OR=7.5), history of central neurological event 
(p=0.003; OR=8.6) and coronary artery bypass grafting (p=0.019; OR=6.0) were independent 
determinants of  temporary neurological dysfunction. Urgency status (p=0.003; OR=8.6) was the 
only independent determinant for permanent neurological dysfunction, and it occurred in 15 
patients (3.7%). 
Conclusion. Antegrade selective cerebral perfusion is an effective method of brain protection. 
Cerebral perfusion times longer than 90 minutes were not associated with an increased risk of 
hospital mortality or poorer neurological outcome. Urgency status and recent history of central 
neurological event were retained as important risk factors for hospital mortality and neurological 
outcome. 
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Despite gradual improvement of the results in surgery of the aortic arch, brain injury still 
remains the most feared complication and frequent cause of death (1-7).  
Available techniques of cerebral protection include Deep Hypothermic Circulatory Arrest 
(DHCA) alone or in combination with Retrograde Cerebral Perfusion (RCP) and Antegrade 
Selective Cerebral Perfusion (ASCP). All three methods have both advantages and disadvantages. 
The purpose of our study was to evaluate the results of ASCP with moderate hypothermic 
circulatory arrest in patients undergoing surgery of the proximal thoracic aorta, with particular 
emphasis on the predictors of hospital mortality and neurological outcome. 
 
Patients and Methods 
Patients’ profile.  After defining common perioperative variables (see Appendix) a total of 413 
medical records of  patients who underwent thoracic aorta operations using ASCP at the St   
Antonius Hospital (Nieuwegein, The Netherlands) and Sant’ Orsola Hospital (Bologna, Italy) 
between October 1995 and May 2001 were retrospectively examined and included in the study.  
There were 268 men (64.9%) and 145 women (35.1%)  whose age ranged from 21 to 85 
years (mean 63.0 ± 11.5 years); 204 (49.4%) were older then 65 years. Of the entire cohort, 288 
patients (69.7%) were operated on electively, 125 (30.3%) underwent urgent operation (116 patients 
sustained acute dissection and 9 impending aneurysmal rupture). Indication for surgery was acute 
type A dissection in 116 patients (28.1%), chronic post dissection aneurysm in 70 (16.9%), 
degenerative  aneurysm in 227 (55.0%). Associated  diseases included Chronic Obstructive 
Pulmonary Disease (COPD) in 44 patients (10.7%), chronic renal dysfunction (defined as a 
creatinine serum level exceeding 250 µmol/L) in 14 (3.4%). Twenty patients (4.8%) had a recent 
history of central neurologic event (transient ischemic attack=9, stroke=11), 60 (14.5%) had 
undergone previous aortic/cardiac surgical procedures through a median sternotomy.  All electively 
operated patients underwent preoperative evaluation of cerebral circulation with Doppler ultrasound 
of the extra-cranial vessels, digital subtraction angiography of the extra-cranial and intra-cranial 
circulation, carotid compression test with monitoring by electroencephalogram to evaluate 
occlusion intolerance or a Trans-Cranial Doppler (TCD) ultrasound study. 
 
Operative technique. Anaesthetic management, methods of brain and myocardial protection were 
similar in both Institutions. 
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Induction of anaesthesia was obtained with propofol 2 mg/kg, fentanyl 2 µg/kg and pancuronium 
0.1 mg/kg. Propofol and fentanyl were used for maintenance of anaesthesia. For all patients, pH 
control was carried out using the alpha-stat method. 
A median sternotomy was used in 395 (95.6%) patients, a  median sternotomy plus anterolateral 
thoracotomy in 6 (1.4%). In the remaining 12 (3%) patients, the diseased aorta was exposed through 
a left posterolateral thoracotomy. After systemic heparinization, cardiopulmonary bypass was 
instituted with a cannula for arterial return in the ascending aorta or in the femoral artery and a 
venous single-two stage cannula in the right atrium or a long venous cannula  through the left 
femoral vein into the right atrium. The left side of the heart was vented through the right superior 
pulmonary vein. Myocardial protection was achieved with cold crystalloid cardioplegia and topical 
pericardial cooling.  
Details of our cannulation technique and method of ASCP with moderate hypothermic circulatory 
arrest have been previously described (8-9). Briefly, after the cardiopulmonary bypass was 
instituted and the patients were cooled to 22-26°C of nasopharyngeal temperature, systemic 
circulation was arrested and the diseased aorta opened. With the patient in Trendelenburg position, 
under direct visual control, in general 15 F retrograde coronary sinus perfusion cannulas (Medtronic 
DLP; Chase Medical Inc, Houston, TX), connected to the oxygenator with a separate single-roller 
pump head, were inserted into the innominate and left common carotid arteries through the aortic 
lumen. After the cannulas were properly placed, the balloons at the tip of the cannulas were 
manually inflated and held in place by an encircling tape. The left subclavian artery was clamped or 
occluded with a Fogarty catheter (Baxter health care, Irvine CA; IFM Clearwater, FL) in order  to 
avoid the steal phenomenon. 
The cerebral perfusion was started at a rate of 10ml/min/kg and adjusted to maintain a right radial 
arterial pressure between 40 and 70 mm of Hg. The introduction of the cerebral perfusion catheters 
usually took less than 3 minutes. 
During open distal anastomosis (10-11), blood perfusion to the lower half of the body from the 
femoral artery, when cannulated, was arrested or reduced to 500 ml/min. 
Tools of cerebral monitoring included: right radial arterial pressure line in all cases, 
electroencephalogram, regional oxygen saturation in the bilateral frontal lobes by means of a near-
infrared spectroscopy (NIRS) , TCD measurement of the blood velocity of the middle cerebral 
artery to confirm the proper placement and function of both cannulas when available. 
Transesophageal echocardiography was routinely used to assess cardiac contractility, blood flow 
conditions, aortic  pathology , intracardiac air. 
The extent of the aortic replacement and the associated procedures are listed  in Table 1 and 2. 
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Table 1. Overview of the extent of the aortic replacement  (N=413) 
Extent of replacement N % 
Ascending aorta + hemiarch 214 51.8 
Ascending aorta + total arch 138 33.4 
Total thoracic aorta 18 4.4 
Arch + descending   aorta 13 3.1 
Isolated arch 24 5.8 
Others 6 1.5 
 
 
Table 2. Overview of the concomitant procedures 
Procedures N % 
Aortic valve replacement 44 10.7 
Bentall procedure 103 24.9 
Aortic valve sparing procedures 15 3.6 
Aortic  valve  suspension 9 2.2 
Homograft 2 0.5 
Elephant trunk 78 18.9 
CABG 13 3.1 
CABG, Coronary Artery Bypass Grafting  
 
En bloc (12) or separated graft techniques were used to reimplant the arch vessels when a complete 
aortic arch replacement was performed.   
 
Definitions of neurological complications.  Patients were considered to have had permanent 
neurological injuries if they exhibit presence of new neurological dysfunction after surgery  whether 
focal injury (stroke) or global (coma), or were found to have new focal or multiple brain lesions 
confirmed by means of  brain CT-scan or MRI. 
Transient neurological dysfunction (TND), as defined by Ergin and associates (13), indicated the 
occurrence of  postoperative confusion, agitation, delirium, prolonged obtundation, or transient 
parkinsonism with negative brain CT scanning and complete resolution before discharge. 
 
Chapter 4 
 - 56 -
Statistical analysis. Continuous variables were expressed as the mean ± one standard deviation, 
and categorical variables as percentages. All preoperative and intraoperative variables were first 
analysed using univariate analysis (unpaired two-tailed t test, Chi-square test or Fisher’s exact test 
when appropriate) to determine whether any single factor influenced hospital mortality and 
neurologic outcome. A p values of less than 0.05 was taken to indicate statistical significance. The 
analysis for permanent neurologic dysfunction and TND were conducted separately. Risk factors 
for permanent neurological dysfunction were examined in all patients who survived the operation 
long enough to undergo neurological evaluation, and risk factors for TND were assessed in all 
operative survivors without permanent neurological dysfunction. Variables that achieved p less than 
0.05 in the univariate analysis were examined using multivariate analysis by forward stepwise 
logistic regression to evaluate independent risk factors for hospital mortality, permanent 
neurological dysfunction  and TND. 
Statistical analysis was performed using SPSS 7.0 statistical software (SPSS Inc, Chicago, IL). 
 
Results 
Cardiopulmonary bypass data. The mean CPB time was 201±62 minutes (range from 85 to 493 
minutes), and the mean myocardial ischemic time was 124±45 minutes (range from 28 to 280 
minutes). The mean ASCP time was 63±39 minutes (range from 16 to 220 minutes) (Fig. 1). Two 
hundred thirty-five patients (56.9%) had a ASCP time longer than 45 minutes and 90 (21.8%) 
longer than 90 minutes.  
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Figure 1. Distribution of patients by antegrade selective cerebral perfusion time. 
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Hospital mortality. Operative mortality was 0.9% (4/413). Thirty-nine patients died during 
hospitalisation, for an overall in-hospital mortality rate of  9.4%. The hospital mortality was 13/288 
(4.5%) for elective and 26/125 (20.8%) for urgent surgery (p = 0.000). Causes of death were: multi 
organ failure (n=15), septic shock (n=4), neurological damage (n=2), myocardial infarction (n=2), 
low cardiac output (n=4), bleeding (n=4), bowel ischemia (n=2), rupture of a distal aneurysm (n=5), 
rupture on a proximal anastomotic site (n=1).  
On univariate analysis, the following factors had a significant influence on hospital mortality: 
urgent status (p = 0.000),  acute dissection (p = 0.000), history of recent central neurological event 
(p = 0.001), preoperative renal insufficiency (p = 0.034). Multivariate analysis revealed urgent 
status (p = 0.000; OR=19.9), history of recent central neurological event (p=0.004; OR=8.0) to be 
independent predictors of hospital mortality (Table 3).   The extent of aortic replacement and ASCP 
duration greater of 90 minutes were not statistically correlated  with an increased risk of hospital 
mortality.  
In 287 patients who underwent elective surgery, univariate analysis indicated age > 65 years (p = 
0.003), COPD (p = 0.014), preoperative renal insufficiency (p = 0.046) and history of recent central 
neurological event (p = 0.057) as adverse risk factors for hospital mortality. In the same group of 
patients, significant predictors of hospital mortality after multivariate analysis were age > 65 years 
(p=0.012; OR=6.1) and history of recent central neurological event (p = 0.017; OR= 5.6). 
 
Hospital morbidity. Permanent neurologic dysfunction, which was evaluated in all patients who 
survived the operation long enough to undergo an adequate neurological examination, was reported 
in 15 of 405 patients (3.7%). Four patients (0.9%) never regained consciousness after surgery; a 
brain CT scan showed multiple cerebral infarctions in these cases; in 11 (2.7%) a focal injury was 
diagnosed. 
In univariate analysis, acute dissection (p=0.007) and urgent status (p=0.003) showed statistically 
significant correlation with the occurrence of permanent neurologic dysfunction. On multiple 
logistic regression analysis, urgent status (p=0.003; OR=8.6) was found to be independent predictor 
of permanent neurologic dysfunction (Table 4).  
Transient neurologic dysfunction, which was evaluated only in patients without permanent 
neurological damages, occurred in 20 of 390 patients (5.1%). 
Acute dissection (p=0.006), urgent status (p = 0.003), history of recent central neurological event (p 
= 0.002), and CABG (p = 0.019) were associated with a significantly increased risk of TND on 
univariate analysis. Stepwise logistic regression indicated urgent status (p = 0.005; OR = 7.5), 
history of recent central neurological event (p = 0.003; OR = 8.6), and CABG (p = 0.013; OR = 6.0) 
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as independent predictor of TND (Table 5). ASCP duration greater of 90 minutes was not a 
significant risk factor for  permanent neurologic dysfunction or TND. 
In the group of the elective patients univariate assessment revealed CABG (p = 0.023) and  aortic 
valve replacement (p = 0.049) to be associated with TND.  
Other postoperative complications were bleeding requiring a repeat thoracotomy in 61 patients 
(14.8%), postoperative myocardial infarction (serum CPK level > 300 IU/L with a CPK/MB 
fraction > 3%)  in 14 patients (3.4%). Pulmonary complications requiring a mechanical ventilatory 
support longer than 5 days occurred  in 57 patients (13.8%); 25 of them underwent urgent surgery 
(p < 0.001). Renal failure requiring temporary haemodialysis occurred in 20 patients (4.8%); 11 of 
them underwent urgent surgery (p< 0.001).  
 
 
 
 
 
Table 3. Univariate and Multivariate Analysis for Hospital Mortality (n = 413).
Variable 
No. 
      of 
patients 
No. of 
hospital      
deaths (%) 
Univariate 
analysis 
(P value) 
Multivariate 
analysis 
(P value) 
 
 
OR 
Acute dissection   0.000   
   Yes 116 24 (20.6)    
   No 297 15 (5)    
Urgency   0.000 0.000 19.9 
   Yes 125 26 (20.8)    
   No    288 13 (4.5)    
History of neurologic event   0.001 0.004 8.0 
   Yes 20 7 (35)    
   No 393 32 (8.1)    
Pre-op renal insufficiency   0.034   
   Yes 14 4 (28.5)    
   No 399 35 (8.7)    
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Table 4. Univariate and Multivariate Analysis for Permanent neurological 
Dysfunction (n = 405). 
Variable 
No. 
of 
patients 
No. 
of 
PND (%) 
Univariate 
analysis 
(P value) 
Multivariate 
analysis 
(P Value) 
 
 
OR 
Acute dissection   0.007   
   Yes 110 9 (8.2)    
   No 295 6 (2.0)    
Urgency   0.003 0.003 8.6 
   Yes 119 10 (8.4)    
   No    286 5   (1.7)    
PND, Permanent Neurological Dysfunction 
 
 
Table 5. Univariate and Multivariate Analysis for Temporary Neurological 
Dysfunction (n = 390). 
Variable 
No. 
of 
patients 
No. 
of 
TND (%) 
Univariate 
analysis 
(P value) 
Multivariate 
analysis 
(P value) 
 
 
OR 
Acute dissection   0.006   
   Yes 101 11 (10.9)    
   No 289 9 (3.1)    
Urgency   0.003 0.005 7.5 
   Yes 109 12 (11)    
   No    281 8 (2.8)    
History of neurologic event   0.002 0.003 8.6 
   Yes 19 5 (26.3)    
   No 371 15 (4)    
Concomitant CABG   0.019  6.0 
   Yes  12 3(25)    
   No 378 17(4.5)    
TND, Temporary Neurological Dysfunction; CABG, Coronary Artery Bypass Grafting 
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Discussion 
 
Although results of aortic arch surgery have improved in the last decades, neurological 
injuries, resulting from interruption of cerebral circulation, still remain the most feared 
complications and frequent cause of death.  Available methods of cerebral protection include 
DHCA with or without RCP and ASCP.   
DHCA provides a still, bloodless operative field and is technically less complicated. Aortic 
arch and arch vessels may be carefully inspected and manipulation can be avoided resulting in a 
reduced cerebral embolic risk. However, this technique has the disadvantage of a limited “safe” 
time of circulatory arrest (1,14,15) and a prolonged cardiopulmonary bypass time is required in 
order to cool down and re-warm the patient which may result  in a number of  pulmonary, renal, 
cardiac, endothelial dysfunction as well as an increased microembolisms production (1,2,16). 
Coagulative complications are associated with deeper levels of hypothermia. We believe DHCA to 
be an excellent method of brain protection when a circulatory arrest time shorter than 30 minutes is 
anticipated.  
RCP was introduced in aortic arch surgery to prolong the “safe” time of circulatory arrest 
(17). Flush out of embolic material (18), cerebral metabolic support (19,20), catabolite removal and 
enhanced cerebral hypothermia maintenance (21) are the supposed neuroprotective mechanisms but 
still remain controversial. Moreover, Griepp and colleagues experimentally found that RCP, 
especially at high pressure, although successful in removing some emboli, may result in cerebral 
injuries (18,22). We had a very limited experience with RCP with results similar to those obtained 
with DHCA alone . 
ASCP, as described by Kazui and colleagues (11) is our first-choice method of cerebral 
protection. It  prolongs the “safe” time of circulatory arrest (8,9,23), improves the cerebral cooling, 
and can be used with moderate hypothermia. Suggested drawbacks of this technique include a 
greater complexity, a cumbersome operative field and the manipulation and cannulation of the arch 
vessels especially in presence of cloth, loose atheroma or dissection.  
In our series the mean ASCP time was 63 minutes whereas 51.8% of patients had only 
hemiarch replacement. Indeed , when ASCP is used, the procedure takes a slightly longer time. 
However, this mean ASCP time was largely influenced by more complex and time consuming 
operations, such as aortic arch replacement with the separated graft technique, in which ASCP 
continued until the concluding anastomosis for the left common carotid artery was performed. 
Actually, in the subgroup of patients having hemiarch replacement the mean ASCP time was 40±20 
minutes (elective repair: 35±19 min, urgent repair: 47±17 min; p=0.001).  In our experience the 
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time required to prepare the aortic arch and to introduce the cannulas into the arch vessels was 
always less then 3  minutes. Our ASCP cannulas are flexible, made of silicon and can be placed 
towards the patient’s head not obscuring the operative field. The potential risk of brain embolism 
can be reduced by means of the separated graft technique where the origin of the arch vessels is 
resected and replaced with an aortic arch branched graft.  In acute dissection cases it was always 
easy to distinguish the true lumen for the arch vessels cannulation. Malpositioning of the ASCP 
cannulas is easily and immediately recognised  by TCD and NIRS measurements.  
In this multicenter study postoperative neurological complications were classified into 2 
groups, ie temporary and permanent neurological dysfunction. 
The temporary neurological dysfunction seems to be a manifestation of subtle but diffuse 
brain injury associated with long-lasting cognitive impairment (24), undetectable by conventional 
imaging techniques and directly correlated to inadequate brain protection.  
Ergin and associates reported an overall TND rate of 19-28% using DHCA (13,24), and an almost 
linear relationship between circulatory arrest time and the occurrence of TND was found. Reich and 
associates (15) demonstrated that a deep hypothermic circulatory arrest time of 25 minutes or more 
and advanced age are associated with memory and fine motor deficits and with prolonged hospital 
stay. Okita and colleagues reported an incidence of severe TND of 25% in 148 patients who 
underwent operations on the aortic arch using DHCA and RCP (25). The same Author (26), in a 
recent prospective study comparing DHCA with RCP and ASCP, reported a significantly higher 
incidence  of TND in the RCP group  (33% vs. 13.3%, p = 0.05), especially when the RCP duration 
was longer than 50 minutes. A significant correlation between the degree of TND and the duration 
of brain circulatory arrest was also demonstrated. Hagl and colleagues (27)  reported an higher rate 
of TND with RCP than with ASCP in a group of 91 patients who required a cerebral protection time 
between 40 and 80 minutes. Furthermore, RCP resulted in no reduction of TND compared with 
DHCA alone. 
In our experience the overall incidence of  TND was 5.1%. Although we did not perform the 
extensive psychological testing as the former mentioned groups did – which might underestimate 
our true incidence of TND – the difference is striking. An ASCP time longer than 90 minutes was 
not significantly correlated with an increased risk of TND. Since our ASCP is performed with 
moderate hypothermic circulatory arrest (nasopharyngeal temperature 22-26°C) instead of profound 
hypothermia, shorter re-warming period is required. This probably results in a reduced risk of 
microembolism and in a better neurologic outcome. Stepwise logistic regression indicated urgent 
status, history of recent central neurological event, and CABG as independent predictors of TND. 
CABG as  independent risk factor for TND confirms our findings in a previous study (8); it  may be 
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speculated (28) that the presence of coronary artery disease, and therefore the necessity of CABG, 
may be a further indication of cerebrovascular disease in these patients, which puts them at higher 
risk of cerebral dysfunction postoperatively.  
In this series, the overall hospital mortality rate was 9.4% and the permanent neurological 
dysfunction  rate 3.6%. This compares favourably with other reports. Kazui  and colleagues (23) 
reported  an early mortality rate of 12.7% in a group of 220 consecutive patients undergoing total 
arch replacement with the aid of  ASCP.  In that series the incidence of permanent neurological 
dysfunction was 3.3%. Preoperative renal failure, pump time longer than 300 minutes, early series 
and shock were independent determinants of hospital mortality while old cerebral infarction and 
pump time longer than 300 minutes were independent determinants for permanent neurological 
dysfunction. No statistical correlation between ASCP time and hospital mortality or adverse 
neurologic outcome was found. In 656 patients undergoing aortic surgery using DHCA, Svensson 
and colleagues (1) reported a hospital survival and a stroke rate of 88% and 7%, respectively. An 
increased risk of stroke in patients treated with periods of circulatory arrest greater of 40 minutes 
and an increased early mortality for circulatory arrest time beyond 65 minutes were observed. Ueda 
(29) reported a hospital mortality of 10% and a stroke rate of 4% in 249 patients undergoing aortic 
arch surgery using RCP as a method of brain protection. RCP time, pump time and advanced age 
were indicated as risk factors for hospital mortality on multivariate analysis. 
In the 413 patients analysed in this study, urgent status and history of recent central neurological 
event were indicated as independent determinants of hospital mortality on multivariate analysis. 
When the elective cases where considered separately, age > 65 years emerged as a further adverse 
risk factor for hospital mortality. Urgent status was again statistically correlated with an increased 
risk of permanent neurological dysfunction and TND together with history of cerebrovascular 
disease and CABG. Patients undergoing urgent surgery had an increased risk of pulmonary and 
renal postoperative complications. Looking at these findings, consistent with other reports 
(1,23,27,28), we speculate that a more aggressive operative timing with an earlier elective aortic 
repair is probably necessary in patients at risk of rupture. Furthermore, the contribution of advanced 
age to hospital mortality might also be reduced. However, in patients with history of 
cerebrovascular disease, further improvements in cerebral protection techniques are required. 
In conclusion, antegrade selective cerebral perfusion is an effective and safe method of brain 
protection allowing time-consuming aortic repairs to be performed with encouraging results in 
terms of hospital mortality and neurological outcome. Urgency status and recent history of central 
neurological event still remain important preoperative risk factors for hospital mortality and 
neurological outcome. 
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Appendix. Preoperative, Intraoperative and 
Postoperative Variables Included in Analysis 
Age> 65 years 
Gender 
Acute dissection 
Status (elective/urgent) 
Preoperative renal insufficiency (creatinine > 250  µmol/L) 
Chronic Obstructive Pulmonary Disease 
History of recent central neurological event (≤6 months) 
Previous cardiovascular surgery through median sternotomy 
Extent of replacement (hemiarch, arch, ascending aorta + arch, 
total  thoracic aorta, arch + descending aorta, others)  
Concomitant aortic valve replacement 
Concomitant aortic valve sparing procedures 
Concomitant aortic valve suspension 
Concomitant Bentall procedure 
Concomitant Homograft 
Concomitant coronary artery bypass grafting 
Elephant trunk 
Cardiopulmonary bypass time > 180 minutes 
Myocardial ischemic time > 120 minutes 
Selective cerebral perfusion time > 90 minutes 
Exitus 
Post-op respiratory failure 
Post-op myocardial infarction 
Post-op haemodialysis 
Bleeding requiring rethoracotomy 
Permanent neurological dysfunction 
Temporary neurological dysfunction 
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Abstract 
 
Background. Antegrade Selective Cerebral Perfusion (ASCP) has proved to be a reliable method of 
brain protection during surgery of the thoracic aorta but its use remains still controversial during 
aortic dissection operations. Here we present our results after operative repair of acute type A aortic 
dissections using ASCP and moderate hypothermic circulatory arrest. 
Methods. Between October 1995 and August 2001, 122 patients underwent repair of acute type A 
aortic dissection with the aid of ASCP and open distal anastomosis. Age was 61±12 (mean ± 
standard deviation), 76 were men. Preoperative complications included cardiac tamponade (n=34; 
27.0%), aortic regurgitation (n=27; 22.1%), new neurological deficits (n=11; 9%).  
Results. Stepwise logistic regression revealed preoperative cardiac tamponade (p = 0.018) and new 
neurological deficits (p = 0.017) to be independent determinants for hospital mortality (19.7%). 
Permanent neurological complications occurred in 7% of patients. Independent risk factors for 
temporary neurological dysfunction (11.2%) included cardiac tamponade (p = 0.019) and 
preoperative neurological deficits (p = 0.000). 
Conclusions. In our experience, the surgical treatment of acute type A aortic dissection with the aid 
of ASCP was associated with acceptable hospital mortality and neurologic morbidity rates.  
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Despite several advances in preoperative recognition, intraoperative techniques and 
postoperative care have been achieved in the last decades, the treatment of acute type A aortic 
dissection is still associated with considerable mortality and morbidity rates (1-4). 
Antegrade Selective Cerebral Perfusion (ASCP) has proved to be a reliable method of brain 
protection during surgery of the thoracic aorta (5-8). However, since manipulation and cannulation 
of the arch vessels are required, its use is still debated during aortic dissection repair.  
The purpose of this study was to review our experience in 122 consecutive patients 
undergoing  surgery for acute type A aortic dissection with the aid of ASCP and to determine risk 
factors associated with hospital mortality and adverse neurologic outcome. 
 
Material and methods 
Patients’ profile. Between October 1995 and August 2001, 122 patients underwent surgical repair 
of acute type A aortic dissection with the aid of ASCP, moderate hypothermia and open distal 
anastomosis at the St. Antonius Hospital (Nieuwegein, the Netherlands) and Sant’ Orsola Hospital 
(Bologna, Italy). Medical records were reviewed for clinical variables including preoperative status, 
intraoperative data, and early postoperative complications. Patients referred for chronic dissections 
were excluded from the study. 
There were 76 men (62.3%), and 46 women ( 37.7%) with a mean age of 61.2±11.2 years, ranging 
from 27 to 81. All patients had precordial, back or abdominal pain at the onset of symptoms. 
Cardiac tamponade (n=34, 27%), new neurological deficits (n=11, 9%), aortic valve insufficiency 
(n=27, 22.1%) and arterial hypertension (n= 52, 42.6%) were the most common preoperative 
findings.   
Preliminary diagnosis at the referring institutions was usually made by means of echocardiography, 
CT scan, or occasionally by angiography. To prevent further delay, it is the policy of our 
institutions to immediately transfer the patient to the operative theatre and to perform a 
transesophageal echocardiogram at the induction of anaesthesia for final diagnostic confirmation.  
The ascending aorta was always involved by the dissection. The tear site was located at the 
ascending aorta in 84 patients (68.9%), at the transverse arch in 24 (19.7%) and at the proximal 
descending thoracic aorta in 3 (2.5%). In the remaining 11 patients (9.0%), an entry tear was not 
found (probably because it was more distally located). 
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Operative technique. A median sternotomy was used in all 122 cases. After systemic 
heparinization, Cardio Pulmonary Bypass (CPB) was instituted with a cannula for arterial return in 
the femoral artery with the best pulsation and a venous single-two stage cannula in the right atrium. 
The left side of the heart was vented through the right superior pulmonary vein. Myocardial 
protection was obtained by means of antegrade or retrograde infusion of cold crystalloid 
cardioplegia and topical pericardial cooling.  
Details of our cannulation technique and method of ASCP with moderate hypothermic circulatory 
arrest have been previously described (9;10). Briefly, after the cardiopulmonary bypass was 
instituted and the patients were cooled to 22-26°C of nasopharyngeal temperature (usually within 
30 minutes), systemic circulation was arrested and the aorta opened. With the patient in 
Trendelenburg position, two 15 F retrograde coronary sinus perfusion cannulas (Medtronic DLP; 
Chase Medical Inc, Houston, TX) were inserted into the innominate and left common carotid 
arteries through the aortic lumen. The left subclavian artery was clamped or occluded with a 
Fogarty catheter (Baxter health care, Irvine CA; IFM Clearwater, FL) in order  to avoid the steal 
phenomenon. 
The cerebral perfusion was started at a rate of 10ml/min/kg and adjusted to maintain a right radial 
arterial pressure between 40 and 70 mm of Hg. During open distal anastomosis (11;12) blood 
perfusion to the lower half of the body from the femoral artery was discontinued. 
After the distal anastomosis was performed, the proximal graft was cross-clamped and the 
extracorporeal circulation reinstituted in antegrade manner trough a side branch of the prosthesis. 
The intimal tear was always resected if located in the ascending aorta or in the transverse arch; the 
false lumen was occluded with a monofilament suture using a Teflon  (C.R. Bard, Tempe, AZUSA) 
felt, gelatine-resorcinol-formaldehyde-glue (GRF-glue, Fii, Sain-Just-Malmont, France) or fibrinous 
glue (Tissue-col, Immuno AG, Vienna, Austria) to reinforce the proximal and distal anastomotic 
sites. The reconstructive material was placed between the dissected aortic layers. 
The extent of the replacement, determined by the intimal tear localisation, and the associated 
procedures are summarised in Table 1.  
When a complete aortic arch replacement was performed, the “en bloc repair” (n=13) (13) or 
“separated graft technique” (n=7) (5) were used to reimplant the arch vessels. 
Tools of cerebral monitoring included: right and left radial arterial pressure lines, 
electroencephalogram (EEG), regional oxygen saturation in the bilateral frontal lobes by means of a 
near-infrared spectroscopy (NIRS) and Trans Cranial Doppler (TCD) measurement of the blood 
velocity of the middle cerebral artery to confirm the proper placement and function of both cannulas 
when available. Transesophageal echocardiography was routinely used. 
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Table 1. Overview of the operative techniques 
Operative techniques No of patients (%) 
Proximal aortic repair a 102 (83.6) 
Distal aortic repair b 20 (16.4) 
Aortic valve replacement 7 (5.7%) 
Composite graft replacement 10 (8.2) 
Aortic valve resuspension 4 (3.3) 
Aortic root remodelling (23) 6 (4.9) 
CABG 4 (3.3) 
Elephant trunk 1 (0.8) 
a Proximal aortic repair: ascending aorta or hemiarch replacement; 
b Distal aortic repair: ascending aorta and transverse arch replacement; 
CABG, Coronary Artery Bypass Grafting 
 
Statistical analysis. Continuous variables were expressed as the mean ± one standard deviation, 
and categorical variables as percentages. All preoperative and intraoperative variables (Table 2) 
were first analysed using univariate analysis (unpaired two-tailed t test, Chi-square test or Fisher’s 
exact test when appropriate) to determine whether any single factor influenced hospital mortality 
and neurologic outcome. A p values of less than 0.05 was considered to indicate statistical 
significance. Variables that achieved p less than 0.05 in the univariate analysis were examined using 
multivariate analysis by forward stepwise logistic regression to evaluate independent risk factors for 
hospital mortality, permanent neurological dysfunction and transient neurologic dysfunction.  
The analysis for permanent neurological dysfunction (stroke or coma) and  transient neurologic 
dysfunction (postoperative confusion, agitation, delirium, prolonged obtundation, or transient 
parkinsonism with negative brain CT scanning and complete resolution before discharge) were 
conducted separately. Risk factors for permanent neurological dysfunction were examined in all 
patients who survived the operation long enough to undergo neurological evaluation. Risk factors 
for transient neurologic dysfunction were assessed in all operative survivors without PND.  
Statistical analysis was performed using SPSS 10.0 statistical software (SPSS Inc, Chicago, IL). 
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Results 
Cardiopulmonary bypass data The mean CPB time was 198±74 minutes (range from 85 to 493 
minutes), and the mean myocardial ischemic time was 115±54 minutes (range from 28 to 267 
minutes). The mean ASCP time was 55±27 minutes (range from 19 to 150 minutes). Sixty-five 
patients (53.3%) had an ASCP time longer than 45 minutes and 36 (29.5%) longer than 60 minutes 
(Fig.1). The mean lowest nasopharyngeal and rectum temperatures were 23.2°C±2.6°C and 
26.1°C±3.5°C, respectively .The mean lowest blood temperature was 18.1 ±3.0°C. 
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Figure 1. Distribution of patients by selective cerebral perfusion time. 
 
Hospital mortality. The overall hospital mortality was 19.7% (24 of 122 patients). Cause of death 
were multiorgan failure (n=10), bleeding (n=4), late residual aneurysm rupture in the ward (n=4), 
cardiac failure (n=2), coma (n=2), intestinal ischemia (n=1), acute myocardial infarction (n=1). 
Preoperative new neurologic deficits (p=0.017; OR=5.6) and cardiac tamponade (p=0.018; OR=5.6) 
were indicated to be independent determinants for hospital mortality by multivariate analysis (Table 
3). Failure to resect the intimal tear as well as prolonged CPB and ASCP times had no impact on  
hospital mortality (Table 2). 
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Hospital morbidity. Two patients who died in the operative room because of bleeding and 5 who 
died because of multi-organ failure (n=3) and cardiac failure (n=2) before sedation could be 
discontinued were excluded from the analysis for neurologic outcome. 
Permanent neurological dysfunction occurred in 8 patients (7%). No predictive risk factors for 
permanent neurological dysfunction were identified by multivariate analysis. 
Transient neurologic dysfunction occurred in 12 of the 107 (11.2%) survivors without permanent 
neurological dysfunction. Stepwise logistic regression indicated preoperative new neurological 
deficits (p=0.000; OR=14.6) and cardiac tamponade (p=0.019; OR=5.4) to be independent 
predictors of transient neurologic dysfunction (Table 3). Failure to resect the intimal tear as well as 
prolonged CPB and ASCP times were not statistically associated with an increased risk of 
permanent or transient neurologic complications (Table 2). 
Other postoperative complications included: renal insufficiency requiring dialysis in 11 patients 
(9%), respiratory insufficiency requiring mechanical ventilatory support longer than 5 days in 27 
(22.1%),  acute myocardial infarction in  7 (5.7%) and bleeding  requiring a rethoracotomy in 17 
(13.9%). 
 
 
Table 2. Univariate analysis of hospital mortality, PND and TND. 
        Hospital mortality PND TND 
Risk factor No. Death (%) p No. PND (%) p No. TND (%)   p 
Age >65   0.649   0.463   0.440
    No 70 21.4  66 9.1  60 10.0  
   Yes 52 17.3  49 4.1  47 12.8  
Gender   0.588   0.362   0.512
   Male 76 19.7  71 5.6  67 11.9  
   Female 46 19.6  44 9.1  40 10.0  
Hypertension   0.371   0.488   0.203
    No 70 21.4  65 6.2  61 8.2  
   Yes 52 17.3  50 8  46 15.2  
Marfan   0.485   0.865   0.787
    No 119 19.3  113 7.1  105 11.4  
   Yes 3 33.3  2 -  2 -  
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Table 2. Continued 
        Hospital mortality PND TND 
Risk factor No. Death (%) p No. PND (%) p No. TND (%)    p 
 
COPD   0.207   0.405   0.481
    No 115 20.9  108 6.5  101 11.9  
   Yes 7 -  7 14.3  6 -  
Renal insufficiency   0.416   0.642   0.519
    No 115 19.1  109 7.3  101 10.9  
   Yes 7 28.6  6 -  6 16.7  
Tamponade   0.029   0.097   0.096
    No 88 14.8  87 4.6  83 8.4  
   Yes 34 32.4  28 14.3  24 20.8  
Neurologic 
symptoms 
  0.039   0.510   0.001
    No 111 17.1  106 7.5  98 7.1  
   Yes 11 45.5  9 -  9 55.6  
Aortic insufficiency   0.553   0.602   0.566
   No 95 20.0  88 6.8  82 11.0  
   Yes 27 18.5  27 7.4  25 12.0  
Redo procedure   0.411   0.746   0.617
    No 118 20.3  111 7.2  103 11.7  
   Yes  4 -  4 -  4 -  
Tear site   0.670   0.117   0.586
   Asc. aorta 84 20.2  81 3.7  78 11.5  
   Arch 24 12.5  22 18.2  18 16.7  
   Prox. desc. ao 3 33.3  2 -  2 -  
   Unknow 11 27.3  10 10  9 -  
Failure to resect the 
tear 
  0.371   0.529   0.328
    No 111 18.9  105 6.7  98 12.2  
   Yes 11 27.3  10 10.0  9 -  
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Table 2. Continued 
        Hospital mortality PND TND 
Risk factor No. Death (%) p No. PND (%) p No. TND (%)   p 
Extent of  
replacement 
  0.589   0.094   0.488
   Asc. aorta/hemiarch  102 19.6  98 5.1  93 10.8  
   Asc. aorta+arch 20 20.0  17 17.6  14 14.3  
Associated 
procedures 
  0.510   0.625  0.598  
    No 94 20.2  87 6.9  81 11.1  
   Yes 28 17.9  28 7.1  26 11.5  
CPB time >180   0.194   0.100   0.245
   No 63 15.9  61 3.3  59 8.5  
   Yes 59 23.7  54 11.1  48 14.6  
Myocardial ischemic 
time >120 
  0.213   0.211   0.509
   No 82 17.1  79 5.1  75 10.7  
   Yes 40 25.0  36 11.1  32 12.5  
ASCP time>60   0.564   0.080   0.522
   No 82 19.5  79 3.8  76 11.8  
   Yes 40 20  36 13.9  31 9.7  
PND, Permanent Neurologic Dysfunction; TND, Transient Neurologic Dysfunction; COPD, Chronic 
Obstructive Pulmonary Disease; CPB, Cardio Pulmonary Bypass; ASCP, Antegrade Selective 
Cerebral Perfusion. 
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Table 3.  Stepwise logistic regression for significant determinants of hospital 
mortality and TND. 
 
Hospital mortality TND 
Predictor p Odds Ratio 95% CL p Odds Ratio 95% CL 
 New neurological 
deficits 
0.017 5.6 1.33-20.22 0.000 14.6 6.40-316.73
Cardiac tamponade  0.018 5.6 1.22-8.96 0.019 5.4 1.38-44.54 
TND, Transient Neurologic Dysfunction. 
 
Comment 
Although surgical outcome in patients with acute type A aortic dissection has substantially 
improved over the last decades, mortality and morbidity rates are still considerable (1-4). 
In our high-risk group of patients (Table 1), hospital mortality, permanent neurological 
dysfunction and transient neurologic dysfunction rates were 19.7%, 7% and 11.2%, respectively. 
Multivariate analysis indicated only preoperative conditions, namely new neurological deficits and 
cardiac tamponade, to be independent predictive risk factors for hospital mortality and transient 
neurologic dysfunction. None of the analysed variables resulted to be statistically correlated with an 
increased risk of permanent neurological dysfunction  . 
It has been demonstrated that a deep hypothermic circulatory arrest (DHCA) time longer 
than 30, 45 and 60 minutes is associated with an increased risk of transient neurologic dysfunction, 
stroke and mortality, respectively (14;15). Therefore, in our series, only 11 patients (9%), who had 
an ASCP shorter than 30 minutes, might have been treated by means of DHCA within the safe time 
limit. Sixty-five (53.3%) patients had an ASCP time longer than 45 minutes and 36 (29.5%) longer 
than 60 minutes (Fig.1). In this study, confirming our pervious findings (6;8-10), the duration of 
ASCP did not affect hospital mortality and neurologic outcome. 
By means of ASCP, the time of circulatory arrest can be safely prolonged compared to deep 
hypothermic circulatory arrest with or without retrograde cerebral perfusion allowing more complex 
repair to be performed (7). This seems to be very important especially in case of acute aortic 
dissection repair, permitting unhurried and accurate reconstruction of the friable aortic tissue or 
more extended aortic replacement. 
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Recent reports (16-21) indicate an higher risk of early mortality when a simultaneous aortic 
arch replacement is performed, ranging from 20% to 55%. In a recent study Kazui et al (22) 
reported an hospital mortality of 21% in a selected group of 70 patients with acute type A aortic 
dissection undergoing complete aortic arch replacement with the aid of ASCP. In our series a 
simultaneous aortic arch replacement was performed in 20 patients (16.7%) with an hospital 
mortality rate of 20% (4/20). The extent of the replacement did not affect neither hospital mortality 
nor neurologic outcome. 
Technical complexity, cumbersome operative field as well as manipulation and cannulation 
of the arch vessels which might be involved in the dissection are considered as possible drawbacks 
of ASCP.  Preparation and insertion of the ASCP catheters take less than 2 minutes in experienced 
hands. Our ASCP cannulas are flexible and can be easily placed towards the patient’s head not 
obscuring the operative field. Furthermore, they are connected to the oxygenator through a separate 
single roller pump allowing a separate control of systemic and cerebral perfusions. Cannulation of 
the arch vessels especially in case of acute dissection is certainly a delicate step, and great care has 
to be taken. However, in our series, no cannulation-related complications occurred. It was always 
possible to distinguish through the aortotomy the true lumen of the arch vessels and to perform, 
under direct visualisation,  a safe cannulation. If the arch vessels are involved in the dissection and a 
simultaneous aortic arch replacement is performed, the “separated graft technique” (22) can be used 
to reimplant the supra-aortic vessels. This will provide an important advantage: the anastomotic 
sutures will be performed more distally on the arch vessels where the dissection has not usually 
extended. 
In our series, no spinal cord injuries occurred  after surgery. The mean circulatory arrest 
time was 55±27 minutes and the mean nasopharyngeal and rectum temperatures were 23°C and 
26°C, respectively. This proves that using ASCP and moderate hypothermia, it is safe to stop the 
body circulation for about 60 minutes. Using ASCP, spinal cord perfusion might be going on 
through the right subclavian and right vertebral arteries as well as through the blocked left 
subclavian and left vertebral arteries. This probably underscores the value of ASCP and the 
importance of blocking the left subclavian artery. 
Cerebral monitoring plays a central part during aortic dissection repair. The installation 
takes few minutes being mostly performed during the induction of anaesthesia and malpositioning 
of the ASCP system as well as cerebral malperfusion at the institution of CPB can be easily and 
immediately detected. If cerebral malperfusion occurs during the cooling period either a different 
arterial inflow site can be selected or, alternatively, if the patient’s temperature is already low 
enough, circulatory arrest and ASCP can be promptly instituted. 
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In summary, during surgery of acute type A aortic dissection, ASCP with moderate 
hypothermia provided a reliable brain protection even in longer period of circulatory arrest which 
are anticipated in this complex form of aortic surgery. ASCP is technically feasible and resulted in 
low neurologic complication rate and acceptable hospital mortality. 
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Abstract 
Objective. To compare the results of ascending aorta/hemiarch replacement using two different 
methods of cerebral protection in terms of hospital mortality, neurological outcome and systemic 
morbidity, and to determine predictive risk factors associated with hospital mortality and 
neurological outcome after ascending aorta/hemiarch replacement. 
Methods. Between January 1995 and September 2001, 289 patients (mean age 62.2± 13.2 years; 
urgent status:122/289, 42.2%) underwent ascending aorta/hemiarch replacement with the aid of 
Antegrade Selective Cerebral Perfusion (ASCP: 161 patients) or Deep Hypothermic Circulatory 
Arrest (DHCA: 128 patients).  
Results. Overall hospital mortality was 11.4% (DHCA group 13.3%, ASCP group 9.9%; p=0.375). 
A logistic regression analysis revealed acute type A dissection (p=0.001;OR=4.3) and age > 70 
years (p= 0.019; OR=2.5) to be independent predictors of hospital mortality. The Permanent 
Neurological Dysfunction (PND) rate was 9.3% (DHCA group 12.5%; ASCP group 7.6%, 
p=0.075). Logistic regression analysis revealed acute type A dissection (0=0.001; OR=6.7) and 
history of Cerebral infarction/Transient ischemic attack (p= 0.038; OR=3.4) to be independent 
predictors of PND. The Transient Neurological Dysfunction (TND) rate was 8.0% (DHCA group 
7.1%; ASCP group 8.7%, p=0.530). Acute type A dissection (p=0.001; OR=5.1) was indicated as 
an independent predictor of TND by logistic regression. Renal dysfunction (postoperative 
creatinine>250 µMol) (DHCA: 10, 7.8%, ASCP: 6, 3.7%; p=0.030) as well as prolonged intubation 
time (DHCA: 3.8±6.3 days, ASCP: 2.2±2.5 days; p=0.005) were more common in the DHCA 
group. 
Conclusion. The use of ASCP and DHCA during ascending aorta/hemiarch replacement resulted in 
acceptable hospital mortality and neurological outcome. Reduced postoperative intubation time and  
better renal function preservation were observed in the ASCP group. 
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Utilisation of optimal methods of brain, spinal and myocardial protection as well as 
prevention and treatment of haemorrhage and coagulopathy are primary concerns during surgery of 
the thoracic aorta. 
Current methods of brain protection include Deep Hypothermic Circulatory Arrest (DHCA), 
Retrograde Cerebral Perfusion (RCP) and Antegrade Selective Cerebral Perfusion (ASCP). All 
three methods  have advantages and disadvantages. 
In our Institution, ASCP is currently the method of choice for cerebral protection, especially 
for patients requiring complex aortic arch repairs. When a Circulatory Arrest (CA) time of less than 
30 minutes is anticipated, the selection of the brain protection method (between DHCA and ASCP) 
depends on the surgeon’s preference. 
This study was undertaken to determine the predictive risk factors associated with hospital 
mortality and neurological outcome in patients undergoing ascending aorta/hemiarch replacement 
with the aid of ASCP and DHCA. A comparison between the two techniques was also performed in 
terms of hospital mortality, neurological outcome and systemic morbidity. 
 
Material and methods 
 
Patients’profile. Between January 1995 and September 2001, 289 patients underwent ascending 
aorta/hemiarch replacement at the St. Antonius Hospital, Department of Cardiothoracic Surgery, 
Nieuwegein, Netherlands.  
Medical records were reviewed for clinical variables including preoperative status, intraoperative 
data and early postoperative complications (see Appendix). 
There were 189 men (65.3%), and 100 women ( 34.7%) with a mean age of 62.2±13.2 years (range 
23 to 85 years). The indications for surgery were acute type A dissection in 122 patients (42.2%), 
and chronic post dissection aneurysm or degenerative  aneurysm in 167 (57.8%).  
Cerebral protection was achieved by means of DHCA in 128 patients (DHCA group, 44.3%)  and 
ASCP and moderate hypothermia in 161 patients (ASCP group, 55.7%). The year in which the  
operation was performed did not influence the selection of the brain preservation technique used. 
Patient demographics were essentially similar in the two groups (Table 1). 
All elective patients underwent preoperative evaluation of cerebral circulation with Doppler 
ultrasound of the extra-cranial vessels, digital subtraction angiography of the extra-cranial and intra-
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cranial circulation, carotid compression test with monitoring by electroencephalogram to evaluate 
occlusion intolerance or a Trans-Cranial Doppler (TCD) ultrasound study when available. 
 
Table 1. Patient Demographics 
 Total group 
(N=289) 
 N, (%) 
DHCA 
(N=128) 
N, (%) 
ASCP 
(N=161) 
N, (%) 
 
 
P value 
Male  189 (65.3) 81 (63.3) 108 (67.5) 0.454 
Age 62.2±13.2 63.0 61.5 0.315 
Acute type A dissection 122 (42.2) 58 (45.3) 64 (39.8) 0.342 
History of hypertension 54 (18.7) 17 (13.3) 37 (23.0) 0.048 
Diabetes 7 (2.4) 3 (2.3) 4 (2.4) 0.156 
CAD 24 (8.3) 16 (12.5) 8 (5.5) 0.030 
Creatinine > 120 µMol/L 26 (9.0) 11 (8.6) 15 (9.3) 0.223 
History of CI, TIA  18 (6.2) 7 (5.5) 11 (6.8) 0.634 
EF%    0.218 
    EF>50% 264 (91.3) 114 (89.1) 150 (93.2)  
    30<EF%<50 25 (8.7) 14 (10.9) 11 (6.8)  
Previous cardiac operation 31 (10.7) 14 (10.9) 17 (10.6) 0.918 
DHCA  = Deep Hypothermic Circulatory Arrest; ASCP = Antegrade Selective Cerebral Perfusion; 
CAD = Coronary Artery Disease; CI = Cerebral Infarction; TIA = Transient Ischemic Attack; EF = 
Ejection Fraction 
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Operative technique. Induction of anaesthesia was obtained with propofol 2 mg/kg, fentanyl 2 
µg/kg and pancuronium 0.1 mg/kg. Anaesthesia was maintained with propofol and fentanyl. For all 
patients, pH balance control was carried out using the alpha-stat method. No pharmacological 
neuroprotective agents were administered. Aprotinine was used sporadically.  
Cerebral monitoring was achieved by means of a right radial arterial pressure line, 
electroencephalogram (EEG), regional oxygen saturation in the bilateral frontal lobes using near-
infrared spectroscopy and TCD measurement of the blood velocity of the middle cerebral arteries. 
The proximal thoracic aorta was approached by means of a median sternotomy in all cases. After 
systemic heparinization, cardiopulmonary bypass (CPB) was instituted with a cannula for arterial 
return to the ascending aorta or the femoral artery, and a venous single two-stage cannula in the 
right atrium. The left side of the heart was vented through the right superior pulmonary vein. 
Myocardial protection was achieved with cold crystalloid cardioplegia and topical pericardial 
cooling maintaining the myocardial temperature at or below 14°C.  
In the DHCA group, core cooling was instituted during CPB to produce profound hypothermia. 
During this period, usually requiring 30-40 minutes, the proximal repair was performed. The head 
was packed in ice to prevent warming of the central nervous system. When a flat-line EEG was 
achieved, circulation was arrested and the distal repair was carried out. On completion of the 
procedure, gradual warming was carried out by means of CPB, limiting the gradient between blood 
and body temperature to less than 10°C, with a maximum blood temperature of 37°C. A warming 
blanket was also used. Central warming was usually discontinued at a rectal temperature of 35°C. 
Details of our cannulation technique and method of ASCP with moderate hypothermic circulatory 
arrest have been previously described (1;2). Briefly, after the cardiopulmonary bypass was 
instituted and the patients were cooled to a nasopharyngeal temperature of 22-26°C, the systemic 
circulation was arrested and the aneurysm opened. With the patient in Trendelenburg position, 15 F  
retrograde coronary sinus perfusion cannulas (Medtronic DLP), connected to the oxygenator with a 
separate single-roller pump head, were inserted into the innominate and left common carotid 
arteries through the aortic lumen. The left subclavian artery was clamped or occluded with a 
Fogarty catheter (Baxter health care, Irvine CA) in order to avoid the steal phenomenon. 
Cerebral perfusion was initiated at a rate of 10 ml/min/kg and adjusted to maintain a right radial 
arterial pressure between 40 and 70 mm of Hg. 
During open distal anastomosis, blood perfusion to the lower half of the body from the femoral 
artery, when cannulated, was arrested or reduced to 500 ml/min. 
The extent of the aortic replacement and the associated procedures are listed  in Table 2. 
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Table 2. Extent of replacement and associated procedures 
 Total group 
N. (%) 
DHCA 
N, (%) 
ASCP 
N, (%) 
p value 
Extent of replacement    0.001 
      Ascending aorta  129 (44.6) 87 (68.0) 42 (26.1)  
      Hemiarch 160 (55.4) 41 (32.0) 119 (73.9)  
Associated procedures (all combined) 152 (52.6) 64 (50) 88 (54.7) 0.431 
AVR 24 (8.3) 19 (14.8) 5 (3.1) 0.001 
Bentall 80 (27.7) 22 (17.2) 58 (36.0) 0.001 
Aortic root remodelling 12 (9.5) 2 (1.6) 10 (6.2) 0.043 
Aortic resuspension 12 (4.2) 3 (2.3) 9 (5.6) 0.169 
Homograft 15 (5.2) 11 (8.6) 4 (2.5) 0.030 
CABG 24 (8.3) 16 (12.5) 8 (5.0) 0.030 
DHCA  = Deep Hypothermic Circulatory Arrest; ASCP = Antegrade Selective Cerebral Perfusion; 
AVR = Aortic Valve Replacement; CABG = Coronary Artery Bypass Grafting. 
 
Statistical analysis. Continuous variables were expressed as the mean ± one standard deviation and 
were analysed by the unpaired two-tailed t test. Categorical variables were presented as percentages 
and were analysed by the Chi-square test or Fisher’s exact test when appropriate. A p value of less 
than 0.05 was considered statistically significant. All preoperative and intraoperative variables were 
first analysed using univariate analysis to determine whether any single factor influenced hospital 
mortality and neurological outcome. Variables that achieved p less than 0.05 in the univariate 
analysis were examined using multivariate analysis by forward stepwise logistic regression to 
evaluate independent risk factors for hospital mortality, Permanent Neurological Dysfunction 
(PND) and Transient Neurological Dysfunction (TND).  
The analysis for PND (stroke or coma) and TND (postoperative confusion, agitation, delirium, 
prolonged obtundation or transient parkinsonism with negative brain CT scanning and complete 
resolution before discharge) were conducted separately. Risk factors for PND were examined in all 
patients who survived the operation long enough to undergo neurological evaluation. Risk factors 
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for TND were assessed in all operative survivors without PND.  Statistical analysis was performed 
using SPSS 10.0 statistical software (SPSS Inc, Chicago, IL). 
 
Table 3. CPB data 
 Total group 
N, (%) 
DHCA 
N, (%) 
ASCP 
N, (%) 
 
P value 
CPB time (min) 198±74 197±54 198±60 0.982 
Myocardial ischemic time (min) 119±46 105±41 129±48 0.001 
Total cerebral protection time (min) 35±21 29±9 42±20 0.001 
Nasopharyngeal temperature (°C)  16.1±2.8 23.2±2.6 0.001 
CPB = Cardio Pulmonary Bypass; DHCA = Deep Hypothermic Circulatory Arrest;  
ASCP = Antegrade Selective Cerebral Perfusion 
Results 
Hospital mortality. Circulatory arrest and perfusion data are summarised in Table 3. 
There were 33 in-hospital deaths (11.4%). Hospital mortality for elective surgery was 5.8% and 
17.8% for urgent surgery (p=0.001). Causes of death were: multi organ failure  (n=14), PND (n=5), 
distal aneurysm rupture (n=4), pneumonia (n=4), haemorrhage (n=2), mediastinitis (n=2), low 
cardiac output (n=1) and bowel ischemia (n=1). 
Univariate analysis revealed that acute type A dissection (p=0.001), age > 70 years (p=0.018), 
history of Cerebral Infarction/Transient Ischemic Attack (CI/TIA) (p=0.041) and Bentall procedure 
(p=0.012) were significant predictors of mortality. A stepwise logistic regression analysis showed 
that acute type A dissection (p=0.001;OR=4.3; 95%CI=1.90-9.67), and age > 70 years (p=0.019; 
OR=2.5; 95%CI=1.57-5.23) were independent predictors of hospital mortality . 
Hospital morbidity.  PND occurred in 27 patients (9.3%). Univariate analysis revealed acute type 
A dissection (p=0.001) and history of CI/TIA (p=0.018) to be predictors of stroke. These findings 
were confirmed by stepwise logistic regression (acute type A dissection p=0.001, OR=6.7, 
95%CI=2.44-18.41; history of CI/TIA p=0.038, OR=3.4, 95%CI=1.07-11.42). 
TND occurred in  21 out of the 262 patients who survived surgery without PND (8.0%). Univariate 
analysis indicated that acute type A dissection (p=0.002) and Ejection Fraction (EF) <50% 
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(p=0.048) were significant predictors of TND. Concomitant procedures (p=0.066) and history of 
CI/TIA (p=0.075) were of borderline significance. Stepwise logistic regression showed acute type 
A dissection (p=0.001; OR=5.1; 95%CI=1.87-14.19) to be an independent predictor of TND. 
Hospital morbidity included pulmonary complications requiring a mechanical ventilatory support 
for more than 5 days in 36 patients (12.5%), renal failure requiring temporary haemodialysis in 5 
patients (1.7%) and postoperative myocardial infarction (serum CPK level >300 IU/L with a 
CPK/MB fraction >3%) in 18 patients (6.2%). Mean drain blood production was 1524±1090 (range, 
180 to 7200). Thirty-five patients (12.1%) underwent  a repeat thoracotomy for bleeding. Patients 
received an average of 5.3±4.2 units of packed red cells (range, 0 to 25). The average blood 
products consumption, defined as fresh frozen plasma and platelets consumption, was 5.7±3.9 units 
per patient (range, 0 to 21). Univariate analysis revealed redo operations (p=0.026) and CPB time > 
240 minutes (p=0.012) to be risk factors for a greater consumption of packed red cells and blood 
products. 
DHCA vs ASCP. The mean CPB times were similar in the DHCA and ASCP groups (DHCA: 
198±54, ASCP: 198±60; p=0.982) as a result of prolonged myocardial ischemic (DHCA: 105±41, 
ASCP: 129±48; p=0.001) and total cerebral protection (DHCA: 29±9, ASCP: 42±20; p=0.001) 
times in the ASCP group (Table 3). In fact, more extended aortic tissue replacement and a larger 
number of aortic root repairs were performed in the ASCP group (Table 2). 
Hospital mortality and morbidity of the two groups are compared in Table  4.  
Hospital mortality was 13.3% (17 out 128) in the DHCA group and 9.9% (16 out of 161) in the 
ASCP group (p=0.375). PNDs were more common in the DHCA group (12.5%) than in the ASCP 
group (7.6%) although statistical significance was not reached (p=0.075). TND occurred in 7.1% of 
the DHCA group and in 8.7% of ASCP group (p=0.530). Univariate analysis (Table 5) revealed that 
a circulatory arrest time of more than 25 minutes was associated with an increased risk of TND in 
the DHCA group (p=0.021) whereas ASCP duration had no impact on neurological outcome (1). 
Renal dysfunction (postoperative creatinine>250 µMol) (DHCA: 10, 7.8%, ASCP: 6, 3.7%; 
p=0.030) as well as prolonged intubation time (DHCA: 3.8±6.3 days, ASCP: 2.2±2.5 days; 
p=0.005) were more common in the DHCA group. No differences were observed between the two 
groups in terms of drain blood production (p=0.809) or packed red cells (p=0.529), and blood 
products consumption (p=0.347). 
 
 
 
                                                             DHCA and ASCP for ascending aorta/hemiarch replacement 
 - 91 -
Table  4. DHCA vs ASCP 
 Total group 
N, (%) 
DHCA 
N, (%) 
ASCP 
N, (%) 
 
P value
Hospital mortality 33 (11.4) 17 (13.3 ) 16 (9.9 ) 0.375 
PND 27 (9.3) 16 (12.5) 11 (7.6) 0.075 
TND 21 (8.0) 8 (7.1) 13 (8.7) 0.530 
Intubation time (days) 2.9±4.6 3.8±6.3 2.2±2.5 0.005 
Post-operative creatinine>250 µMol/L 16 (5.5) 10 (7.8) 6 (3.7) 0.030 
Post-operative dialysis 5 (1.7) 1 (0.8) 4 (2.5) 0.270 
Post-operative MI 18 (6.2) 7 (5.5) 11 (6.8) 0.634 
Rethoracotomy for bleeding  35 (12.1) 18 (14.1) 17 (10.6) 0.365 
Drain blood production 1524±1090 1542±1242 1509±952 0.809 
Packed red cells  5.3±4.2 5.4±5.0 5.1±3.5 0.529 
Blood products consumption. 5.7±3.9  5.4±4.0  5.9±3.7 0.347 
DHCA  = Deep Hypothermic Circulatory Arrest; ASCP = Antegrade Selective Cerebral Perfusion; 
PND = Permanent Neurological Dysfunction; TND = Transient Neurological Dysfunction; 
AMI = Acute Myocardial Infarction 
 
 
Table 5. TND patient distribution by DHCA time.  
 
 DHCA  time < 25 min DHCA time > 25 min P Value 
 
    
TND    
0.021 
          Yes 1 (1,9%) 7 (11,9%)  
    
 
           No 52 (98,1%) 52 (88,1%)  
    
 
TND = Transient Neurological Dysfunction; DHCA = Deep Hypothermic Circulatory Arrest  
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Discussion 
 
Despite the fact that the results of the surgery of the thoracic aorta have gradually improved, 
hospital mortality, and neurological and systemic complications still remain considerable.   
In our series, hospital mortality was 11.4%, (5.8% and 17.8% in elective and urgent 
procedures, respectively). Acute type A aortic dissection and advanced age were independent 
predictors of hospital mortality confirming previous reports (1, 3, 4). PND and TND rates were 
9.3% and 8%, respectively. 
In accordance with other clinical reports (3, 4), the presence of acute type A aortic dissection 
and a history of CI/TIA predicted the occurrence of postoperative adverse neurological outcome. 
Washiyama and colleagues (5) have demonstrated that a canine brain having a previous cerebral 
infarction is more susceptible to ischemia during aortic arch operation using ASCP as a 
consequence of an accelerated anaerobic metabolism and an increased extracellular glutamate 
release in the brain from the previous infarction. Kazui and colleagues (6) recently reported a 
postoperative PND rate of 3.3% in a group of 220 patients undergoing aortic arch replacement using 
aortic branched grafts and ASCP. The presence of a previous cerebral infarction was an 
independent determinant of PND with a relative risk of 21.8 on multivariate analysis. Similarly, a 
history of cerebrovascular disease has been shown to be an independent predictor of postoperative 
stroke in aortic arch replacement using DHCA alone (3;4). 
Deep hypothermic circulatory arrest with or without RCP and ASCP are currently being 
used as methods of brain protection.   
Technical simplicity, and avoidance of aorta and arch vessels manipulation as well as a 
bloodless operative field make DHCA an attractive method of brain protection especially during 
ascending aorta/hemiarch replacement when a short period of circulatory arrest is anticipated. 
However, hypothermia-associated coagulopathy (7), and pulmonary, renal and microembolic 
complications (8) are important disadvantages cited in the literature. 
ASCP provides several advantages: the circulatory arrest time can safely be extended up to 
90 minutes (1) allowing more complex aortic repair to be performed and moderate (nasopharyngeal, 
25°C) instead of profound hypothermia can be used with reduced coagulative and systemic 
complications. Criticism against ASCP includes technical complexity, reduced surgical visibility, 
and manipulation of the aortic arch and arch vessels especially in case of acute dissections or 
severely atherosclerotic aortic arch aneurysms. 
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In the current study, we compared DHCA and ASCP in terms of hospital mortality, and 
neurological and systemic morbidity in a group of patients undergoing ascending aorta/hemiarch 
replacement. 
In our series, the ASCP group patients had a more extended aortic tissue replacement and a larger 
number of aortic root repairs. Nevertheless, hospital mortality and neurological outcome were 
comparable in the two groups; reduced intubation time and better renal function recovery were 
noted in the ASCP group.  
TND seems to be a manifestation of subtle but diffuse brain injury associated with long-
lasting cognitive impairment undetectable by conventional imaging techniques and directly 
correlated to inadequate brain protection (9).  
In our series, a circulatory arrest time of more than 25 minutes was associated with an increased risk 
of TND in the DHCA group. 
Reich and colleagues (10) have demonstrated that a deep hypothermic circulatory arrest time of 25 
minutes or more is associated with memory and fine motor deficits, and with prolonged hospital 
stays. McCullough and colleagues (11) have recently demonstrated that the cerebral metabolic rate 
is still 17% of the baseline at 15°C and that the safe duration of circulatory arrest at 15°C is only 29 
minutes. These findings probably indicate that circulatory arrest times of 45-60 minutes were too 
optimistically indicated as safe (4). 
Surprisingly, no significant differences in terms of rethoracotomy for bleeding, drain blood 
loss and blood products consumption was observed between the two groups. This was probably due 
to similar mean CPB times in the two groups or to damage of the blood components occurring 
during perfusion through the small ASCP cannulas. 
In conclusion, even though this study carries the risks inherent to the use of retrospective 
data, some important conclusions can be reached: 1) the utilisation of DHCA and ASCP resulted in 
acceptable results in terms of hospital mortality and neurological outcome during ascending 
aorta/hemiarch replacement, 2) only preoperative patient characteristics such as acute type A aortic 
dissection, age >70 years and history of CI/TIA affected hospital mortality and neurological 
outcome, 3) in the DHCA group, a circulatory arrest time of more than 25 minutes was associated 
with an increased risk of TND and 4) reduced postoperative intubation time and better renal 
function recovery were observed in the ASCP  group. 
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Appendix.  
Age > 70 years 
Gender 
Acute dissection 
Status (elective/urgent) 
Ejection fraction  
Hypertension 
Diabetes  
Preoperative renal creatinine (µmol/L) 
Preoperative dialysis 
History of central neurological events 
Previous cardiovascular surgery by means of median 
sternotomy 
Extent of replacement (ascending aorta/hemiarch) 
Associated procedures (all combined) 
Concomitant aortic valve replacement 
Concomitant aortic valve sparing procedures 
Concomitant aortic valve suspension 
Concomitant Bentall procedure 
Concomitant homograft 
Concomitant coronary artery bypass grafting 
Cardiopulmonary bypass time 
Cardiopulmonary bypass time > 240 minutes 
Myocardial ischemic time 
Myocardial ischemic time > 120 minutes 
Selective cerebral perfusion time 
Exitus 
Post-op intubation time (days) 
Post-op myocardial infarction 
Post-op creatinine >250 µMol/L 
Post-op haemodialysis 
Blood drain production (cc) 
Bleeding requiring rethoracotomy 
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Appendix. Continued 
Packed red cells consumption (units) 
Blood products consumption (units) 
Permanent neurological dysfunction 
Transient neurological dysfunction 
 
 
 
.  
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Abstract 
Objectives. To compare the results of the separated graft technique and the en bloc technique as a 
method of arch vessels reimplantation during surgery of the aortic arch and to determine predictive 
risk factors associated with hospital mortality and adverse neurologic outcome during aortic arch 
repair. 
 Methods. Between October 1995 and March 2002, 352 patients (mean age 64.9±11.3 years; urgent 
status: 49/352; 13.9%) underwent surgery of the aortic arch using the Separated Graft Technique 
(SGT group: n=230; 65.3%) and the En Bloc Technique (EBT group: n=122; 34.7%) to reimplant 
the arch vessels. An aortic arch replacement was performed in 32 patients (9.1%), an ascending 
aorta and arch replacement in 222 patients (53.1%), an aortic arch and descending aorta 
replacement in 16 patients (4.5%) and a complete replacement of the thoracic aorta in 82 patients 
(23.3%). Brain protection was achieved by means of Antegrade Selective Cerebral Perfusion 
(ASCP) in all cases. The mean Cardio Pulmonary Bypass (CPB) time was 204.8±61.9 minutes 
(SGT group: 199.7±57.0 min; EBT group: 214.5±69.4 min; p= 0.033), the mean myocardial 
ischemic time was 121.5±43.2 minutes (SGT group: 116.7±38.9 min; EBT group: 130.80±49.4 
min; p=0.003) and the mean ASCP time was 84.5±36.4 (group A: SGT; 91.3±36.3 min; EBT 
group: 70.6±32.7 min;p=0.000).  
Results. Overall hospital mortality was 6.8% (SGT group: 6.5%; EBT group: 7.4%; p=ns). The 
Permanent Neurological Dysfunction (PND) rate was 3.5% (SGT group: 4.0%; EBT group: 2.5%; 
p=ns). The Transient Neurological Dysfunction (TND) rate was 5.4% (SGT group: 5.5%; EBT 
group: 5.2%, p=ns). Postoperative systemic morbidity was similar in the two groups. A logistic 
regression analysis revealed preoperative cardiac tamponade (p=0.011;OR=5.9) and CPB time 
(p=0.010; OR=1.01/min) to be independent predictors of hospital mortality. None of the analysed 
preoperative variables were associated with an increased risk of PND. Age > 70 years (p=0.029; 
OR=5.7), CABG (p=0.001; OR=2.9) and CPB time (p=0.013; OR=1.01/min) were indicated as 
independent predictors of TND by logistic regression.  
Conclusions. ASCP was confirmed to be a safe method of cerebral protection allowing complex 
aortic arch operations to be performed with acceptable results in terms of hospital mortality and 
neurologic outcome. The separated graft technique had no adverse impact on hospital mortality and 
morbidity. 
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Protection of the brain from ischemic/embolic injuries and selection of adequate operative 
techniques are primary concerns during surgery of the aortic arch. 
In our institutions, a progressive improvement of survival and neurologic outcome in 
patients undergoing complex aortic repairs has gone through the following steps: 
1) Utilisation of Antegrade Selective Cerebral Perfusion (ASCP) and moderate hypothermia as a  
method of brain protection for aortic operations requiring a circulatory arrest longer than 30 
minutes. 
 2) Utilisation of alternative cannulation sites such as the ascending aorta and the right axillary 
artery in combination with antegrade resumption of the Cardio Pulmonary Bypass (CPB) to reduce 
cerebral embolic injuries. 
The En Bloc Technique (EBT) and the Separated Graft Technique (SGT) are currently being 
used as a method of arch vessels reimplantation during aortic arch reconstructions.  
The objectives of the present study were: 1) to determine the independent predictive risk 
factors for hospital mortality and neurologic outcome in 352 patients undergoing aortic arch 
replacement with the aid of ASCP; 2) to compare (and comment on) the two different techniques 
for aortic arch vessels reimplantation during aortic arch operations. 
Material and methods 
Patients’profile. Between October 1995 and March 2002, 352 patients underwent surgery of the 
aortic arch at the St Antonius Hospital (Nieuwegein, The Netherlands), at the Hamamatsu 
University (Hamamatsu, Japan) and at the Sant’Orsola Hospital (University of Bologna, Bologna, 
Italy) (Table 1). 
 
Table 1. Study centers 
St. Antonius Hospital 
Nieuwegein, Netherlands 
1995-2002 
N° cases = 142 
University of Bologna 
Bologna, Italy 
1996-2002 
N° cases = 125 
University of Hamamatsu 
Hamamatsu, Japan 
1997-2002 
N° cases = 85 
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 The  arch vessels were reimplanted on the aortic arch using the Separated Graft Technique (SGT 
group: n=230; 65.3%) or the En Bloc Technique (EBT group: n=122; 34.7%). Brain protection was 
achieved by means of ASCP in all cases. 
Medical records were reviewed for clinical variables including preoperative status, intraoperative 
data and early postoperative complications. 
 
Table 2. Patient Demographics 
 Total group 
N=352 
N (%) 
En Bloc 
N=122 
N (%) 
Sep. Graft  
N=230 
N (%) 
 
 
p value 
Male  178 (50.6) 77(63.1) 101(43.9) 0.001 
Age 64.9±11.3 63.9±10 65.4±12 Ns 
Acute type A dissection 49(13.9) 17(13.9) 32(13.9) Ns 
History of hypertension 236 (67.3) 75(57.1) 161(70.2) Ns 
CAD 50 (14.2) 11(9.0) 39(17.0) 0.028 
Creatinine > 120 µMoll/L 20 (5.7) 6(4.9) 14(6.1) Ns 
COPD 47(13.4) 13(10.7) 34(14.8) Ns 
History of cerebrovascular disease  40 (11.4) 8(6.6) 32(13.9) 0.026 
Acute aortic insufficiency 8(2.3) 3(2.5) 5(2.2) Ns 
Tamponade  12 (3.4) 5(4.1) 7(3.0) Ns 
Previous cardiac operation 60 (17.0) 24(19.7) 36(15.7) Ns 
CAD = Coronary Artery Disease; COPD = Chronic Obstructive Pulmonary Disease 
 
There were 178 men (50.6%); the mean patients age was 64.9±11.3 years (range 23 to 85). The 
indications for surgery were acute type A dissection in 49 patients (13.9%) and chronic post 
dissection aneurysm or degenerative  aneurysm in 303 (86.1%). Two hundred and thirty-six patients 
(67.3%) presented with arterial hypertension, 50 (14.2%) had coronary artery disease, 40 (11.4%) 
had history of cerebrovascular disease, 47 (13.4%) had chronic obstructive pulmonary disease, and 
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20 (5.7%) had chronic renal insufficiency (creatinine > 120 µMoll/L). Out of 49 patients with type 
A aortic dissection, 12 (24.4%) presented with cardiac tamponade and 8 (16.3%) with acute aortic 
insufficiency. Sixty patients (17%) had undergone a previous cardiovascular operation using a 
median sternotomy. Patient demographics were essentially similar in the two groups. The SGT 
group had more coronary disease and more history of cerebrovascular disease as compared to the 
EBT group (Table 2). 
All elective patients underwent preoperative evaluation of cerebral circulation with a Doppler 
ultrasound of the extra-cranial vessels, digital subtraction angiography of the extra-cranial and intra-
cranial circulation, a carotid compression test with monitoring by electroencephalogram to evaluate 
occlusion intolerance or a Trans-Cranial Doppler (TCD) ultrasound study when available. 
 
Operative technique. Induction of anaesthesia was obtained with propofol 2 mg/kg, fentanyl 2 
µg/kg and pancuronium 0.1 mg/kg. Anaesthesia was maintained with propofol and fentanyl. For all 
patients, pH balance control was carried out using the alpha-stat method. No pharmacological 
neuroprotective agents were administered. Our platform for cerebral monitoring has previously 
been described (1;2) and included a right radial arterial pressure line in all cases, 
electroencephalogram, regional oxygen saturation in the bilateral frontal lobes by means of a near-
infrared spectroscopy (NIRS), jugular venous oxygen saturation and TCD measurement of the 
blood velocity of the middle cerebral artery when available. Transesophageal echocardiography was 
routinely used. 
To approach the thoracic aorta, a median sternotomy was used in 347 patients (98.6%) and a 
median sternotomy plus left anterolateral thoracotomy in 5 patients (1.4%). After systemic 
heparinization, CPB was instituted with a cannula for arterial return in the femoral artery, ascending 
aorta or right axillary artery, and with a venous single two-stage cannula in the right atrium for 
venous drainage. The left side of the heart was vented through the right superior pulmonary vein. 
Myocardial protection was achieved with cold crystalloid or blood cardioplegia. 
Details of our cannulation technique and method of ASCP with moderate hypothermic circulatory 
arrest have previously been described (3-5). Briefly, after the cardiopulmonary bypass was 
instituted and the patients were cooled to a nasopharyngeal temperature of 22-26°C, the systemic 
circulation was arrested and the aorta opened. With the patient in the Trendelenburg position, 
special catheters for ASCP (Fuji System Corporation, Tokyo, Japan) (6) or 15 F ordinary retrograde 
coronary sinus perfusion cannulas (Medtronic DLP; Chase Medical Inc, Houston, TX), connected to 
the oxygenator with a separate single-roller pump head, were inserted into the innominate and left 
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common carotid arteries through the opened aorta. The left subclavian artery was clamped or 
occluded with a Fogarty catheter (Baxter health care, Irvine CA) in order to avoid the steal 
phenomenon. 
Cerebral perfusion was initiated at a rate of 10ml/min/kg and adjusted to maintain a right radial 
arterial pressure of between 40 and 70 mm of Hg.  
During open distal anastomosis, blood perfusion to the lower half was usually arrested.  
If the EBT was used for arch vessels reimplantation, an aortic cuff containing the orifices of the 
arch vessels was prepared and anastomosed in an end-to-side fashion to the side hole of the aortic 
graft (7). Following the reconstruction of the arch vessels, the ASCP catheters were removed, and 
after careful deairing, the aortic graft was cross-clamped and CPB was restarted in an antegrade 
fashion through a side branch of the aortic graft or through the axillary artery. Rewarming was 
initiated. The proximal end of the graft was then anastomosed to the proximal stump of the 
ascending aorta. 
Our technique of aortic arch replacement with a 4-branched aortic graft (SGT) has already been 
described in detail (8). After circulatory arrest was established, with the patient in the 
Trendelenburg position, the aorta was opened and the arch vessels completely transected 1.5-2 cm 
from the junction with the aortic arch. The ASCP catheters were inserted into the innominate artery 
and the left common carotid artery while the left subclavian artery was occluded. ASCP was started. 
The distal side of the arch graft was anastomosed to the proximal descending aorta, and the third 
branch was anastomosed to the left subclavian artery. The graft was cross-clamped proximally, and 
antegrade extracorporeal circulation was restarted from the fourth branch, together with rewarming. 
The proximal graft was anastomosed to the ascending aorta and coronary circulation was started. 
The first and second branches of the graft were then anastomosed to the innominate and left 
common carotid artery, respectively. Once CPB was discontinued, the fourth branch, used for 
antegrade perfusion, was oversewn and resected.  
In order to further reduce the duration of spinal cord ischemia we have recently modified our 
technique. The distal side of the arch graft was anastomosed to the proximal descending aorta under 
systemic circulatory arrest, the graft was cross-clamped proximally, and then antegrade systemic 
perfusion was started from the fourth branch of the graft. Then, the left subclavian artery was 
sutured to the third branch of the graft, and rewarming was started. The proximal graft was 
anastomosed to the ascending aorta and coronary circulation was started. The first and second 
branches of the graft were then anastomosed to the innominate and left common carotid artery, 
respectively. Once CPB was discontinued, the fourth branch, used for antegrade perfusion, was 
oversewn and resected. 
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The extent of the aortic replacement and the associated procedures are listed in Table 3, and the 
operative data in Table 4. 
 
Table 3. Extent of aortic repair and associated procedures 
 Total group 
N=352 
N (%) 
En Bloc 
N=122 
N (%) 
Sep. Graft  
N=230 
N (%) 
 
 
P value 
Extent of aortic replacement    Ns 
   Aortic arch 32(9.1) 9(7.4) 23(10.0)  
   Ascend aorta+arch 222(53.1) 93(76.2) 129(56.1)  
   Total thoracic aorta 82(23.3) 8(6.6) 74(32.2)  
   Aortic arch+descending aorta 16(4.5) 12(9.8) 4(1.7)  
AVR 20(5.7) 8(6.6) 12(5.2) Ns 
Bentall procedure 67(19) 33(27.0) 34(14.8) 0.007 
Aortic root remodelling 6(1.7) 4(3.3) 2(0.9) Ns 
Aortic commisures resuspension 5(1.4) 2(1.6) 3(1.3) Ns 
Associated aortic procedures 98(27.8) 47(38.5) 51(23.3) 0.002 
CABG 33(9.4) 8(6.6) 25(10.9) Ns 
MVP/R 4(1.1) 2(1.6) 2(0.9) Ns 
Elephant trunk 111(31.5) 41(33.6) 70(30.4) Ns 
Associated procedures 
(all combined) 
149(42.3) 57(46.7) 92(40.0) Ns 
AVR = Aortic Valve Replacement; CABG = Coronary Artery Bypass Grafting;  
MVP/R = Mitral Valve Plasty/Replacement 
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Table 4. Perfusion data. 
 Total group 
N=352 
N (%) 
En Bloc 
N=122 
N (%) 
Sep. Graft  
N=230 
N (%) 
 
 
P value 
CPB time (min) 204.8±61.9 214.5±69.4 199.7±57.0 0.033 
Myocardial ischemic time (min) 121.5±43.2 130.80±49.4 116.7±38.9 0.003 
ASCP time (min) 84.5±36.4 70.6±32.7 91.3±36.3 0.000 
Nasopharyngeal temp (°C) 21±4.0 22.8±2.8 20.0±4.1 0.000 
Rectum temperature (°C) 23±3.5 25.0±3.2 22.6±3.4 0.000 
CPB = Cardio Pulmonary Bypass; ASCP = Antegrade Selective Cerebral Perfusion 
Statistical analysis. Continuous variables were expressed as the mean ± one standard deviation and 
were analysed by the unpaired two-tailed t test. Categorical variables were presented as percentages 
and were analysed by the Chi-square test or Fisher’s exact test when appropriate. A p value of less 
than 0.05 was considered statistically significant. All preoperative and intraoperative variables were 
first analysed using univariate analysis to determine whether any single factor influenced hospital 
mortality and neurological outcome. Variables which achieved p less than 0.05 in the univariate 
analysis were examined using multivariate analysis by forward stepwise logistic regression to 
evaluate independent risk factors for hospital mortality, Permanent Neurological Dysfunction 
(PND) and Transient Neurological Dysfunction (TND).  
The analysis for PND (stroke or coma) and TND (postoperative confusion, agitation, delirium, 
prolonged obtundation or transient parkinsonism with negative brain CT scanning and complete 
resolution before discharge) were conducted separately. Risk factors for PND were examined in all 
patients who survived the operation long enough to undergo neurological evaluation. Risk factors 
for TND were assessed in all operative survivors without PND.  Statistical analysis was performed 
using SPSS 10.0 statistical software (SPSS Inc, Chicago, IL). 
 
Results 
Hospital mortality. Twenty-four patients died during hospitalisation, for an overall in-hospital 
mortality rate of  6.8%. The hospital mortality was 16/303 (5.3%) for elective surgery and 8/49 
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(16.3%) for urgent surgery (p = 0.010). Causes of death were: multi organ failure (n= 11), septic 
shock (n=2), neurological damage (n=2), low cardiac output (n=3), bleeding (n=3), rupture of a 
distal aneurysm (n=3). 
On univariate analysis, the following factors had a significant influence on hospital mortality: 
urgent status (p = 0.010), acute dissection complicated by tamponade (p = 0.006), preoperative 
renal insufficiency (p = 0.039) and prolonged CPB time (240.1±83.9 vs. 202.2±59.2; p=0.004). 
Multivariate analysis revealed type A aortic dissection complicated by tamponade (p = 0.011; 
OR=5.9) and CPB time (p=0.010; OR=1.01/min) to be independent predictors of hospital mortality 
(Table 5). 
 
Table 5. Univariate and multivariate analysis for hospital mortality (n=352) 
 Hospital mortality     
Factor N % Univariate Multivariate OR 95% CI 
Status  P=0.010    
   Urgent 8/49 16.3     
   Elective 16/303 5.3     
Renal Insufficiency  P =0.039    
   Yes 4/20 20.0     
   No 20/322 6.0     
Tamponade  P =0.006 p=0.011 5.9 1.90-26.48 
   Yes  4/12 33.3     
   No 20/340 5.9     
CPB time 
(minutes) 
240.1±83.9 vs 
202.2±59.2 
P =0.004 p =0.010 1.01/min 1.01-1.14 
CPB, Cardio Pulmonary Bypass; CI, Confidence Interval. 
 
Hospital morbidity. Permanent neurologic dysfunction, which was evaluated by surgeons, 
anaesthesiologists and neurologists in all patients who survived the operation long enough to 
undergo an adequate neurological examination, was reported in 12 of 345 patients (3.5%). No 
significant predictive risk factors for PND were indicated by univariate and multivariate analysis.  
Transient neurologic dysfunction, which was evaluated only in patients without permanent 
neurological damage, occurred in 18 of 333 patients (5.4%). 
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Age > 70 years (p=0.022), coronary artery disease (p=0.025), aortic valve replacement (p=0.017), 
coronary artery bypass grafting (p=0.016) and CPB time (233.7±58.5 Vs 200.2±57.3; p = 0.019) 
were associated with a significantly increased risk of TND on univariate analysis. Stepwise logistic 
regression indicated age > 70 years (p=0.029; OR=5.7), CPB time (p=0.013; OR=1.01/min) and 
coronary artery bypass grafting (p = 0.001; OR = 2.9) as independent predictors of TND (Table 6).  
 
Table 6. Univariate and multivariate analysis for transient neurologic dysfunction 
(n=333) 
 TND     
Factor N % Univariate Multivariate OR 95% CI 
Age > 70 years   p=0.022 P=0.029 5.7 1.14-24.80
   Yes 16/207 7.7     
   No 2/126 1.6     
CAD  p=0.025    
   Yes 6/46 13     
   No 12/287 4.2     
AVR  p=0.017    
   Yes 4/20 20.0     
   No 14/313 4.5     
CABG  p=0.016 P=0.001 2.9 0.90-10.20
   Yes  5/30 16.7     
   No 13/303 4.3     
CPB time 
(minutes) 
233.7±58.5 vs 200.2±57.3 p=0.019 P=0.013 1.01/min 1.32-11.04
 TND = Transient Neurologic Dysfunction; AVR = Aortic Valve Replacement; CABG = Coronary 
Artery Bypass Grafting;CPB = Cardio Pulmonary Bypass 
 
ASCP time was not associated with increased hospital mortality and adverse neurologic outcome. 
Other postoperative complications included bleeding requiring a repeat thoracotomy in 32 patients 
(9.7%), postoperative myocardial infarction (serum CPK level > 300 IU/L with a CPK/MB fraction 
> 3%)  in 4 patients (1.2%). Pulmonary complications requiring a mechanical ventilatory support 
longer than 5 days occurred  in 61 patients (17.6%) and renal failure requiring temporary 
haemodialysis occurred in 16 patients (4.5%). An increased risk for prolonged intubation time was 
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observed in patients with age > 70 years [46/216 (21.3%) Vs 15/231 (11.5); p=0.020] having a 
prolonged CPB time [219.8±58.5 minutes Vs 199.38±58.7 minutes, p=0.014]. An increased risk for 
postoperative haemodialysis was observed in patients with age > 70 years [14/216 (21.3%) Vs 
2/131 (1.5%); p=0.035] having a prolonged CPB time [234.8±60.8 minutes Vs 201.4±58.7 minutes; 
p=0.027]. An increased risk for rethoracotomy due to bleeding was observed in patients undergoing 
redo operations [11/56 (19.6%) Vs 21/273 (7.7%); p=0.04], associated procedures [22/138 (15.6%) 
Vs 16/191 (5.2%); p=0.002] and having a prolonged CPB time [248.3±67.6 minutes Vs 199.5±56.2 
minutes; p=0.001]. 
No differences in terms of hospital mortality, neurologic outcome or other postoperative 
complications were observed between the SGT group and the EBT group (Table 7). 
 
Table 7. En Bloc Technique vs Separated Graft Technique 
 Total group 
N=352 
N (%) 
En Bloc 
N=122 
N (%) 
Sep. Graft  
N=230 
N (%) 
 
 
P value 
Hospital mortality 24(6.8) 9(7.4) 15(6.5) Ns 
PND 12/345(3.5) 3(2.5) 9(4.0) Ns 
TND 18/333(5.4) 6(5.2) 12(5.5) Ns 
Postop dialysis 16(4.5)  6(5.0) 10(4.4) Ns 
Postop respiratory insufficiency 61(17.6) 20(16.7) 41(18.1) Ns 
Postop myocardial infarction 4(1.2) 2(1.7) 2(0.9) Ns 
Postop rethoracotomy 32(9.7) 14(12.6) 18(8.3) Ns 
PND = Permanent Neurologic Dysfunction; TND = Transient Neurologic Dysfunction 
Comment 
Protection of the brain against ischemic injuries during aortic arch exclusion, avoidance of 
embolic strokes and adoption of adequate operative techniques are primary concerns during aortic 
arch procedures. 
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In our Institutions, ASCP is the method of choice during complex aortic arch reconstruction 
for the following reasons: 
1. we demonstrated that an ASCP time longer than 90 minutes and the extent 
of the aortic replacement are not associated with an increased risk of  
hospital mortality and adverse neurologic outcome (9). In this series, the 
prolonged ASCP time observed in the SGT group did not result in an 
increased hospital mortality and adverse neurologic rates 
2. ASCP is associated with a lower incidence of TND in patients undergoing 
aortic arch reconstruction of 40-80 minutes as compared to DHCA with or 
without RCP (10)  
3. it may be used with moderate hypothermia instead of deep hypothermia 
with consequent reduction of the duration of the CPB (11) 
4. ASCP is more effective in supplying oxygenated blood to the brain resulting 
in a more physiological brain energy metabolism and cerebral function 
preservation as compared to DHCA with or without RCP (12-15). 
We tried to reduce our stroke rate by avoiding, when possible, a retrograde arterial perfusion 
from the femoral artery and preferring alternative cannulation sites such as the ascending aorta or 
the right axillary artery (16-18). Restarting the CPB in and antegrade fashion through the side 
branch of the aortic graft or through the axillary artery may also reduce the embolic load to the 
brain, and during dissection repairs, prevent both organ malperfusion and excessive stress on the 
distal suture line.  
Different techniques for aortic arch reconstruction have been described (7;8;10). 
In our Institutions, EBT and SGT are currently being used as techniques for arch vessel 
reimplantation during aortic arch reconstruction. SGT was preferred to EBT when the aortic arch 
and the arch vessels were significantly involved by atheroma, clots or dissection. 
The SGT presents several advantages: 
1. the cerebral embolic risk may be reduced by replacing the aortic arch and 
proximal portion of the arch vessels where clots, atheroma and calcification 
are very often located. We do not believe that the insertion of the catheters 
results in a significantly increased risk of embolization. In fact, aortic 
manipulation is carefully avoided until circulatory arrest is established. The 
arch vessels are transected 1.5-2.0 cm distally from the junction with the 
aortic arch where the likelihood of dislodging debris is low, the arch vessel 
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cannulation is performed under direct visualisation and the balloons at the 
tip of the catheters are not traumatic and even more distally placed. In our 
series, the SGT group had a higher predicted risk of postoperative PND as 
compared to the EBT group, the incidence of preoperative old brain 
infarction being higher (19) and the atherosclerotic involvement of the 
aorta more severe (20). Despite that, the SGT group stroke rate compared 
favourably with the EBT group stroke rate (SGT group: 4.0%; EBT group: 
2.5%; p=ns), and with that reported by others (10;21;22) 
2. CPB time and myocardial ischemic time are shorter than those necessary in 
EBT. It is well-known that pump time is one of the most important risk 
factor for hospital mortality. In our series, a prolonged CPB time was 
associated with an increased risk of hospital mortality, TND, bleeding and 
pulmonary/renal dysfunction after surgery. However, using the SGT did 
not result in better hospital survival nor in a lower morbidity. 
3. lower body ischemia can be substantially reduced  
4. the utilisation of a four branched aortic graft can maximally reduce 
ischemia in the left subclavian artery region (8) 
5. pathological portions of the aortic arch can be completely resected in 
Marfan patients 
6. anastomosis can be performed at the intact distal site of the arch vessels 
where dissection has not extended 
7. bleeding at the site of the arch vessel anastomosis can be easily controlled 
Hagl (10), Spielgovel (23) and Rokkas (24) have described different techniques for aortic 
arch replacement: first, the arch vessels are anastomosed to a main aortic graft as separate grafts or 
in an island fashion under a period of deep hypothermic circulatory arrest. After establishing ASCP 
through the graft (or axillary artery), the distal and proximal aortic anastomosis are accomplished. 
These techniques require a period of deep hypothermic circulatory arrest of about 30 minutes for 
the arch vessels reconstruction, prolonged periods of spinal cord ischemia and probably result in a 
more technically demanding distal anastomosis since the aortic graft makes the operative field 
cluttered. With SGT, since safe brain protection is guaranteed by ASCP and moderate hypothermia, 
distal anastomosis becomes the most important part of the procedure. Thus, we perform it as first, 
with open technique. Moreover, with SGT, the duration of the total circulatory arrest required to 
open the aorta, transect and cannulate the arch vessels with our balloon catheters is reduced to about 
3 minutes, and spinal cord ischemia is maximally reduced. 
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In this series involving 352 patients undergoing aortic arch replacement with ASCP for brain 
protection and SGT and EBT for arch vessels reimplantation, the hospital mortality rate was 6.8%; 
PND and TND rates were 3.5% and 5.4%, respectively. Given the pathological background of the 
patients, the complexity of the reconstructions and the high rate of associated procedures, these 
results can be considered satisfactory. Confirming our previous reports, type A aortic dissection 
complicated by tamponade, and CPB time were indicated as independent predictive risk factors for 
hospital mortality; CPB time, CABG and age > 70 years were associated with an increased risk of 
TND (3;9;25;26). This finding confirmed that the duration of ASCP and the extent of aortic 
replacement does not impact the patients’ outcome and that the CPB time remains the most 
important intraoperative factor to influence results during complex aortic repairs. Even though SGT 
did not result in an improved survival nor in a better neurologic outcome as compared to EBT, it 
provided numerous technical advantages and required shorter periods of CPB and cardiac ischemia. 
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Brain protection is a primary concern during surgery of the thoracic aorta.  
Based on the suggestion that transient neurologic dysfunction results from inadequate brain 
protection from ischemia during the period of aortic arch exclusion and that permanent neurologic 
damage has an embolic origin (1), different strategies to protect the brain have been introduced in 
the last decade and have been continuously ameliorated in their clinical application.   
These include a) methods based on the idea that when reducing cerebral oxygen consumption 
and/or maintaining cerebral blood flow, cerebral tolerance to ischemia can be safely extended so 
that the surgeon may exclude the cerebral circulation for the time required to perform the aortic arch 
reconstruction (2) (3;4) and b) surgical techniques effective in reducing embolic load to the brain by 
avoiding retrograde perfusion of the thoraco-abdominal aorta from the femoral artery (5-7). 
ASCP and DHCA with or without RCP, represent current methods of brain protection. The three 
methods all have advantages and disadvantages.  
At the St Antonius Hospital, as well as at the University of Bologna (Italy) and at the University 
of Hamamatsu (Japan) with whom I have had the privilege to collaborate, ASCP is, for the 
following reasons the method of choice for brain protection when aortic reconstruction is 
anticipated to require a period of circulatory arrest longer than 30 minutes: 
1. An early contribution from Svensson et al. (8) documented, in a series of 656 patients 
undergoing aortic arch operations with DHCA, an increased risk of stroke and early 
mortality  for periods of circulatory arrest longer than 45 and 60 minutes, respectively. This 
report did not take into consideration the postoperative occurrence of transient neurologic 
dysfunction. In more recent reports based on accurate neurocognitive testing before and 
after surgery, it has been demonstrated that transient neurologic dysfunction can no longer 
be considered a benign self-limited condition, but rather a long lasting neurocognitive 
dysfunction capable of reducing the patients’ quality of life by impairing  memory and fine 
motor functions (9). Confirming recent reports (10;11), we found that periods of circulatory 
arrest under deep hypothermia which are much shorter than 45 minutes (25 minutes) are 
associated with an increased risk of transient neurologic dysfunction (Chapter 6). As 
compared to DHCA with or without RCP, ASCP provides a much longer period of safe 
circulatory arrest. We have demonstrated (Chapter 3-4) that the extent of the aortic 
replacement and an ASCP time of longer than 90 minutes are not associated with an 
increased risk of hospital mortality and adverse neurologic outcome intended as the 
postoperative occurrence of permanent and transient neurologic dysfunctions. Hagl et al. 
have demonstrated the protective effect of ASCP as compared to DHCA with or without 
RCP in reducing the incidence of transient neurologic dysfunction in patients having a total 
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period of brain protection between 40 and 80 minutes (12). For less complex aortic 
procedures requiring a period of circulatory arrest shorter than 30 minutes such as ascending 
aorta/hemiarch replacement, hospital mortality and neurologic outcome are expected to be 
similar whether DHCA or ASCP are used. However,  it is reasonable to expect a poorer 
postoperative renal and pulmonary function recovery if DHCA is selected as a method of 
brain protection (Chapter 6). 
2. ASCP can be used with moderate (instead of deep) hypothermia. Kazui et al. have 
demonstrated that, at a rectal temperature of 25°C with a perfusion pressure of 40 mmHg or 
more, a cerebral flow rate of half of the physiological value is optimal to maintain an 
aerobic cerebral metabolism (13). The Japanese group also demonstrated that under α-stat 
pH management, at a temperature of 20°C with a perfusion pressure of 40 mmHg or more, 
cerebral autoregulation is maintained. These findings constitute the scientific background of 
our clinical ASCP application which includes a flow rate of 10 ml/min/kg, a perfusion 
pressure between 40 and 70 mmHg, a cerebral perfusate temperature of 20°C and a 
nasopharyngeal temperature at circulatory arrest of 22°-25°C. Cooling down the patient’s 
core temperature to only 22°-25°C instead of 10°-18°C, as suggested by other Authors 
(12;14;15), is supposed to have various advantages: 
The duration of CPB can be significantly reduced and survival increased. If it is true 
that CPB duration is the most important risk factor for hospital mortality during 
surgery of the thoracic aorta (8;16;17), an improved hospital survival may be 
expected if the implementation of moderate hypothermia instead of deep 
hypothermia can result in a significant reduction of CPB time. Moreover, better 
postoperative pulmonary and renal function recovery can also be expected if 
intervals of CPB are reduced. 
Coagulative disorders can be reduced. It has been documented that deep 
hypothermia causes alterations in the normal blood coagulation mechanism. 
Hypothermia can produce a shortening of coagulation time. Antithrombin activity  
shows a marked rise after rewarming, while prothrombin and factor VII remain at a 
low level for several days. An increase in fibrinolytic activity has been reported in 
experimental animals. Moreover, prolonged periods of perfusion for cooling and 
rewarming have been shown to exhaust clotting factors and interfere with blood 
coagulation (18). Connolly et al. observed a reduction in platelet counts to below 
15,000 during cooling, as well as increased fibrinolytic activity on rewarming (19). 
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Unfortunately, in Chapter 6 which described two groups of patients undergoing 
ascending aorta/hemiarch replacement with two different methods of brain protection 
involving moderate and profound hypothermia (ASCP vs. DHCA), we were not able 
to demonstrate the benefits of using moderate hypothermia in terms of bleeding 
complications and coagulative disorders probably due to the fact that mean CPB 
times were similar in the two groups as a result of a more aggressive extent of the 
aortic replacement and more associated procedures in the ASCP group.  
 .  
3. The entire experimental literature, comparatively investigating the effects of ASCP, DHCA  
and RCP on  brain energy metabolism, supports the idea that ASCP is superior to the other 
methods in maintaining an aerobic brain metabolism even after a prolonged period of 
circulatory arrest as demonstrated by morphologic, histopathologic and biochemical findings 
as well as by behavioural and clinical examinations (Chapter 1) 
 
4. Manipulation and cannulation of the arch vessels have been indicated as important 
drawbacks of ASCP since they a) increase the embolic risk in patients with atherosclerotic 
aortic arch aneurysms, b) increase the risk of damage of the arch vessels and brain 
malperfusion  in patients with acute aortic dissection and c) make a complex procedure even 
more complex due to reduced surgical visibility and to the necessity of preparing the arch 
vessels and installing the ASCP system. Certainly, the cannulation of the arch vessels 
represents an important phase of the procedure and great care has to be taken. However, in 
our experience it always took less than 3 minutes to insert the ASCP cannulas into the arch 
vessels and to establish cerebral perfusion. Surgical visibility can be adequate if the ASCP 
catheters are placed towards the patient’s head. They are minimally traumatic and positioned 
quite distally in the arch vessels where the likelihood of plaque, atheroma, cloths or 
dissection is very low. It was always easy, during dissection repairs, to identify the true 
lumen of the arch vessels through the aortotomy, and our cerebral monitoring tools could 
always confirm the correct positioning of the catheters and the symmetric distribution of 
blood to the two hemispheres.  In cases of severe atheroma, cloths or dissection involving 
both the aortic arch and the proximal portion of the arch vessels the separated graft 
technique may be effective in reducing the brain embolization risk and in improving the 
neurologic outcome of  patients (Chapter 7) 
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Current strategies to reduce the stroke rate in patients undergoing surgery of the thoracic 
aorta aim to avoid a retrograde perfusion of the thoraco-abdominal aorta intended as a source of 
dislodging embolic material destined to brain vascularization. Thus, alternative and more central 
cannulation sites for CPB institution, such as the ascending aorta and the right axillary artery, 
have gained a wider consensus in many Institutions and are very often preferred to the more 
traditional femoral artery. Furthermore, to reduce embolic phenomena from the distal aorta, 
antegrade perfusion through the side branch of the aortic graft or through the axillary artery can 
be instituted after the distal anastomosis is completed. 
 
However, although the utilisation of ASCP and of alternative cannulation sites have been 
indicated as best tools to protect the brain from ischemic/embolic injuries, as confirmed by 
continuously improving reported neurologic outcomes, transient and permanent neurologic 
damage continues to occur, frequently causing death.  
The aim of the present thesis was to identify, among intraoperative and postoperative factors, 
those that may result in increased hospital mortality and an adverse neurologic outcome.  
Interestingly, the extent of the aortic replacement and the duration of ASCP did not increase the 
risk of hospital mortality and neurologic outcome. This underscores the fact that ASCP provides 
the unique advantage of facilitating complex and time consuming aortic arch operations 
permitting unhurried and meticulous aortic reconstructions which seems to be of particular 
importance during dissection repairs. 
Among the intraoperative variables, type A dissection, urgency and history of stroke/TIA, 
emerged as the most important risk factors for hospital mortality and adverse neurologic 
outcome. The duration of CPB was the only intraoperative factor indicated as a risk factor for 
hospital mortality and neurologic outcome by our statistical analysis.  
The difference observed between our elective and urgent results is still important. If, on the 
one hand, this constitutes a good reason to accelerate the diagnostic process and to shorten the 
pathway to the operative theatre for patients with type A acute dissection, at the same time 
making available the most innovative technologies of cerebral monitoring and the best surgical 
techniques and strategies of cerebral protection, on the other hand, it allows us to consider more 
aggressive surgical timing to operate, under elective circumstances, on those patients at high 
risk of rupture or dissection such as patients with Marfan syndrome, connective disorders and 
bicuspid aortic valves.  
The finding that a history of cerebrovascular disease emerged as a risk factor for adverse 
neurologic outcome is consistent with other studies on CABG (20) and aortic surgery using 
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DHCA with or without RCP (1;8). A history of cerebrovascular disease suggests existing 
pathologic cerebrovascular condition, such as impaired cerebral blood flow and autoregulation 
or inadequate collateral vessels, which may predispose patients to having a stroke after a 
cardiovascular operation (7). Therefore, for patients with cerebrovascular disease, further 
improvement in brain protection methods will be necessary. 
The finding that CPB time is a risk factor for hospital mortality confirmed that ASCP with 
moderate hypothermia has to be preferred to DHCA with or without RCP, since it requires a 
shorter period of CPB to cool down and rewarm the patient.   
 
Conclusions.  
 
In our experience, ASCP has been demonstrated to be a safe and reliable method of brain 
protection  allowing complex aortic procedures to be performed with acceptable results in terms 
of hospital mortality and adverse neurologic outcome.  
ASCP duration does not increase the risk of hospital mortality and adverse neurologic 
outcome permitting unhurried and meticulous aortic reconstruction.  It can be safely used with 
moderate hypothermia requiring a shorter duration of CPB as compared to DHCA with or 
without RCP.  
A DHCA time of longer than 25 minutes seems to be associated with an increased risk of 
transient neurologic dysfunction.  
More aggressive surgical timing for patients at risk of rupture/dissection and adjunctive 
improvements in brain protection methods for patients with cerebrovascular disease will 
probably contribute to further reducing hospital mortality and adverse neurologic outcome in 
our patients. 
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SUMMARY           
Chapter 1 reviews the current methods of brain protection employed during surgery of the thoracic 
aorta, namely deep hypothermia and circulatory arrest, retrograde cerebral perfusion, and antegrade 
selective cerebral perfusion.  Finally, the aim of the present thesis is provided. 
 
In Chapter 2 the neuromonitoring platform currently used at the St Antonius Hospital during aortic 
arch operations, including bilateral radial artery pressure, electro-encephalographic monitoring, 
bilateral transcranial Doppler and Near Infrared Spectroscopy is described and commented. 
 
Chapter 3 analyses the results from the initial experience of the department of cardiovascular 
surgery of the university of Bologna (Italy) in 96 patients undergoing operations on the thoracic 
aorta using antegrade selective cerebral perfusion and moderate hypothermia. The hospital mortality 
rate was  11.5%, the permanent and transient neurologic deficit rate were 1% and 8.3%, 
respectively. On logistic regression type A acute aortic dissection, preoperative renal dysfunction, 
coronary artery bypass grafting, postoperative pulmonary complication and rethoracotomy for 
bleeding were indicated as independent predictive risk factors for hospital mortality. Coronary 
artery bypass grafting was indicated as the only independent predictive risk factor for any 
neurologic deficit on logistic regression.   
 
Chapter 4 analyses the combined experience of the department of cardiovascular surgery of the 
university of Bologna (Italy) and of the department of cardiopulmonary surgery of the St Antonius 
Hospital (Nieuwegein, the Netherlands) in 413 patients operated on for aortic arch aneurysm and 
type A acute dissection using antegrade selective cerebral perfusion. This method resulted to be safe 
and effective in protecting the brain  from ischemic injuries. In fact, the hospital mortality rate was 
9.4% and  permanent and transient neurologic deficit rates were 3.7% and 5.1%, respectively. 
Cerebral perfusion periods of longer than 90 minutes were not associated with an increased risk of 
hospital mortality or poorer neurologic outcome making this method of brain protection extremely 
useful during complex aortic arch repair. Urgency status and recent history of neurologic events 
were indicated as important risk factors for hospital mortality and adverse neurologic outcome. 
 
Chapter 5 is intended to give an answer to those who debate the utilisation of antegrade selective 
cerebral perfusion in patients undergoing type A dissection repair. In 122 patients undergoing  
surgical treatment of acute type A aortic dissection with the aid of antegrade selective cerebral 
perfusion no arch vessels cannulation-related complications occurred, hospital mortality and 
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neurologic morbidity rates were acceptable and comparable to those reported by other groups 
preferring different methods of brain protection.  
 
Chapter 6 compares the results of ascending aorta-hemiarch replacement by using two different 
methods of brain protection (antegrade selective cerebral perfusion and deep hypothermic 
circulatory arrest) in terms of hospital mortality, neurologic outcome and systemic morbidity.  
In this group of patients , requiring a relatively short time of circulatory arrest, both methods 
resulted in positive results of hospital mortality and neurologic outcome. However, the utilisation of  
antegrade selective cerebral perfusion resulted in a better pulmonary and renal function recovery 
after surgery and deep hypothermic circulatory arrests longer than 25 minutes were associated with 
an increased risk of transient neurologic dysfunction. 
 
Chapter 7 examines a complex group of 352 patients undergoing total arch replacement using the 
en bloc technique and the separated graft technique to reimplant the arch vessels.  Although no 
differences in terms of hospital mortality and neurologic outcome were observed between the two 
techniques, the separated graft technique 1) seems to be more appropriate in patients with atheroma, 
cloth and calcification in the proximal portion of the arch vessels in order to reduce the brain 
embolic risk, 2) allows the surgeon to perform the anastomosis at the intact distal site of the arch 
vessels where dissection has usually not extended  3) is associated with reduced durations of 
cardiopulmonary bypass and myocardial ischemia, 3) may provide some useful technical 
advantages in this high risk group of patients. 
 
Chapter 8 is a comprehensive discussion in which the most important results and conclusion of this 
thesis are summarised. 
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Samenvatting         
Hoofdstuk 1 is een overzicht van de huidige toegepaste methoden van hersenbescherming tijdens 
chirurgie van de thoracale aorta, namelijk diep hypotherm circulatoir arrest, retrograde cerebrale 
perfusie, en antegrade selectieve cerebrale perfusie. Uiteindelijk wordt het doel van deze thesis 
uiteengezet. 
 
In Hoofdstuk 2 wordt het neuromonitoring programma, zoals dat tegenwoordig wordt toegepast in 
het St. Antonius Ziekenhuis tijdens operaties aan de aortaboog , inclusief bilaterale arteria radialis 
drukmeting, electro-encephalografie monitoring, bilaterale transcraniële doppler en infrarood 
spectroscopie beschreven en van commentaar voorzien. 
 
Hoofstuk 3 beschrijft de resultaten van de initiële ervaringen van de afdeling cardiovasculaire 
chirurgie van de universiteit van Bologna (Italië) wat betreft 96 patiënten die een operatie aan de 
thoracale aorta ondergingen waarbij gebruik werd gemaakt van antegrade selectieve cerebrale 
perfusie en gematigde hypothermie. De ziekenhuis mortaliteit bedroeg 11.5%, de permanente en 
passagère neurologische stoornissen bedroegen respectievelijk 1% en 8.3%. Logistische regressie 
analyse wees acute type A aortadissectie, preoperatief nierfalen, coronairchirurgie, postoperatieve 
pulmonale complicaties en rethoracotomie voor bloeding, aan als onafhankelijke voorspellende 
risicofactoren voor ziekenhuis mortaliteit. Coronairchirurgie bleek, met logistische regressie 
analyse, de enige onafhankelijke voorspellende risicofactor voor elke neurologische stoornis te zijn. 
 
Hoofdstuk 4 beschrijft de gecombineerde ervaringen van de afdeling cardiovasculaire chirurgie van 
de universiteit van Bologna (Italië) en de afdeling cardiothoracale chirurgie van het St Antonius 
Ziekenhuis (Nieuwegein, Nederland) wat betreft 413 patiënten die geopereerd waren in verband 
met een aneurysma van de aortaboog of  in verband met een acute type A aortadissectie waarbij 
gebruik werd gemaakt van antegrade selectieve cerebrale perfusie. Dit bleek een veilige en 
effectieve methode om de hersenen te beschermen tegen ischemische schade. De ziekenhuis 
mortaliteit was 9.4% en de permanente en passagère neurologische stoornissen bedroegen 3.7% en 
5.1% respectievelijk. Een cerebrale perfusieduur langer dan 90 minuten was niet geassocieerd met 
een verhoogd risico voor ziekenhuis mortaliteit of met slechtere neurologische resultaten, wat 
betekent dat deze methode van hersenbescherming bijzonder toepasbaar is tijdens complexe 
operaties van de aortaboog. Spoedoperatie en recente neurologische stoornissen bleken belangrijke 
risicofactoren te zijn voor ziekenhuis mortaliteit en neurologische stoornissen. 
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Hoofdstuk 5 heeft de bedoeling een antwoord te geven aan hen die twijfelen aan het toepassen van 
antegrade selectieve cerebrale perfusie bij patiënten die geopereerd worden voor een type A 
aortadissectie. Bij 122 patiënten die een operatie ondergingen voor een acute type A aortadissectie 
met behulp van antegrade selectieve cerebrale perfusie, traden geen complicaties op die gerelateerd 
waren aan het canuleren van de boogvaten; ziekenhuis mortaliteit en neurologische morbiditeit 
waren acceptabel en vergelijkbaar met de beschreven resultaten van andere groepen die een 
voorkeur hebben voor alternatieve methoden van hersenbescherming.  
 
Hoofdstuk 6 vergelijkt de resultaten van vervanging van de aorta ascendens-partiële boog met 
gebruik van twee verschillende methoden van hersenbescherming (antegrade selectieve cerebrale 
perfusie en diep hypotherm circulatoir arrest) met het oog op ziekenhuis mortaliteit, neurologische 
uitkomst en systemische morbiditeit. In deze patiëntengroep, waarbij een relatief korte tijd 
circulatoir arrest nodig was, resulteerden beide methoden in gunstige resultaten wat betreft 
ziekenhuis mortaliteit en neurologische uitkomst. Echter, het gebruik van antegrade selectieve 
cerebrale perfusie resulteerde in een beter pulmonaal en nierfunctie herstel na chirurgie en diep 
hypotherm circulatoir arrest langer dan 25 minuten was geassocieerd met een verhoogd risico op 
passagère neurologische stoornissen. 
 
Hoofdstuk 7 beschrijft een complexe groep van 352 patiënten die een totale boogvervanging 
ondergingen met behulp van de en-bloc techniek en de separate graft techniek om de boogvaten te 
reïmplanteren. Alhoewel geen verschillen in ziekenhuis mortaliteit en neurologische uitkomst 
werden gevonden tussen de twee technieken, bleek de separate graft techniek 1) meer geschikt voor 
patiënten met atheromen, stolsels en verkalkingen in het proximale deel van de boogvaten met het 
doel het risico op cerebrale embolieën te verminderen, 2) het de chirurg mogelijk te maken om de 
anastomose te maken ter hoogte van de onbeschadigde distale zijde van de boogvaten waar de 
dissectie doorgaans niet was voortgeschreden, 3) geassocieerd met kortere cardiopulmonale bypass 
duur en myocard ischemie duur, 4) mogelijk te kunnen zorgen voor technische voordelen in deze  
patiëntengroep met verhoogd risico. 
 
Hoofdstuk 8 is een uitgebreide discussie waarin de meest belangrijke resultaten en conclusies van 
deze thesis worden samengevat. 
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